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METHOD AND SYSTEM FOR PRODUCING 
TRITERPENES 
CROSS-REFERENCE TO RELATED 
APPLICATION 
This application claims the benefit of U.S. Provisional 
Application Ser. No. 61/711,654, filed Oct. 9, 2012, herein 
incorporated by reference. 
FIELD OF THE INVENTION 
The presently-disclosed subject matter relates to methods 
and systems for producing triterpenes, and in particular to 
methods and systems for producing triterpenes, including 
methylated triterpenes, using expression vectors, isolated 
gene sequences and genetically engineered, i.e. transgenic 
organisms, including yeast and plants, which can be used for 
the production of triterpenes. 
BACKGROUND OF THE INVENTION 
Triterpenes are terpenes consisting of six isoprene units 
having a molecular formula C30H48 . Animals, plants and 
fungi (e.g. yeast), create triterpenes such as squalene and 
botryococcene. In recent years, studies have been conducted 
exploring the uses of triterpenes as biofuels and petroleum 
chemicals. 
Triterpenes may be methylated, for example in the form 
of mono- and di-methylated forms including mono- and 
di-methylated forms of squalene and botryococcene to name 
two, as well as other triterpenes. In nature, for example, 
animal, plant and fungi, triterpenes metabolism occurs in the 
cytoplasm utilizing the mevalonate (MVA) pathway. FIG. 1 
is a schematic showing typical triterpene metabolism occur-
ring in the cytoplasm of animal plant and fungi cells (left 
portion, FIG. 1). In nature, and in particular in plant cells 
having chloroplast, monoterpenes and diterpenes are pro-
duced in chloroplasts using the methyl erythrithol phosphate 
(MEP) pathway, for example as shown in the right side of 
FIG. 1. However, the MEP pathway occurs exclusively in 
the chloroplast compartment and is responsible for monoter-
pene, diterpene and polyterpene (carotenoids and phytol) 
biosynthesis but not triterpene biosynthesis. 
Botryococcus braunii accumulates very high levels of 
methylated triterpenes, compounds that contribute to the 
buoyancy of the algae and serve as high-valued feedstocks 
for the petrochemical and chemical industries. Three SAM-
dependent methyltransferases catalyzing successive and 
regia-specific methylations of either squalene or botryococ-
cene are identified. Methylation of the triterpene analogs 
squalene and botryococcene requires distinct methyltrans-
ferases. The observed substrate selectivity and successive 
cycles of regia-specific catalysis by triterpene methyltrans-
ferases from Botryococcus braunii provides evidence that 
further chemical diversification is achievable. 
2 
long-chain, cross-linked biopolymers formed in part from 
acetalization of polymethylsqualene dials (7) Di- and tetra-
methylated botryococcenes are generally the most abundant 
triterpenes accumulating in race B with smaller amounts of 
tetramethylated-squalene (8) and other structural derivatives 
of squalene and botryococcene that range from C31 to C37 
accumulating to various levels in different strains and in 
response to variable culture conditions (9) Other polymeth-
ylated derivatives such as diepoxy-tetramethylsqualene 
10 (10), botryolins (11), and brauixanthins (12) have also been 
reported. 
B. braunii race B has received significant attention 
because it is considered an ancient algal species dating back 
at least 500 MYAand is one ofthe few organisms known to 
15 have directly contributed to the existing oil and coal shale 
deposits found on Earth (13-15), accounting for up to 1.4% 
of the total hydrocarbon content in oil shales (16) Secondly, 
because the hydrocarbon oils of B. braunii race Bare readily 
converted to starting materials for industrial chemical manu-
20 facturing and high quality fuels under standard hydrocrack-
ing/distillation conditions in yields approaching 97% (17), 
race B has been considered a potential production host for 
renewable petrochemicals and biofuels. However, the slow 
growth habit of B. braunii poses serious limitations to its 
25 suitability as a robust biofuel production system. 
B. braunii race B accumulates triterpene oils in excess of 
30% of its dry weight. The composition of the triterpene oils 
is dominated by di-methylated to tetra-methylated forms of 
botryococcene and squalene. While unusual mechanisms for 
30 the biosynthesis of the botryococcene and squalene were 
recently described, the enzyme(s) responsible for decorating 
these triterpene scaffolds with methyl substituents were 
unknown. A transcriptome of B. braunii was screened com-
putationally assuming that the triterpene methyltransferases 
35 (TMTs) might resemble the SAM-dependent enzymes 
described for methylating the side chain of sterols. Six sterol 
methyltransferase-like genes were isolated and functionally 
characterized. Three of these genes when co-expressed in 
yeast with complementary squalene synthase or botryococ-
40 cene synthase expression cassettes resulted in the accumu-
lation of mono- and di-methylated forms of both triterpene 
scaffolds. Surprisingly, TMT-1 and TMT-2 exhibited pref-
erence for squalene as the methyl acceptor substrate, while 
TMT-3 showed a preference for botryococcene as its methyl 
45 acceptor substrate. These in vivo preferences were con-
firmed with in vitro assays utilizing microsomal preparations 
from yeast over-expressing the respective genes, which 
encode for membrane associated enzymes. Structural exami-
nation of the in vivo yeast generated mono- and di-methyl-
50 ated products by NMR identified terminal carbons, C3 and 
C22/C20, as the atomic acceptor sites for the methyl addi-
tions to squalene and botryococcene, respectively. These 
sites were identical to those previously reported for the 
triterpenes extracted from the algae themselves. The avail-
55 ability of closely related triterpene methyltransferases 
exhibiting distinct substrate specificities and successive 
catalytic activities provides an important tool for investigat-
ing the molecular mechanisms responsible for the specifici-
Botryococcus braunii is a colony-forming, freshwater 
green algae reported to accumulate 30 to 86% of its dry 
weight as hydrocarbon oils (1) Three distinct races of B. 
braunii have been described based on the types of hydro- 60 
carbons that each accumulates (2) Race A accumulates fatty 
acid-derived alkadienes and alkatrienes (3), race L accumu-
lates the tetraterpene lycopadiene (4), and race B accumu-
lates triterpenes, predominately botryococcene, squalene 
and their methylated derivatives (5) The oils accumulate 
both in intracellular oil bodies and in association with an 
extracellular matrix (6), which in race B consists largely of 
ties exhibited by these unique enzymes. 
As previously noted, B. braunii has attracted considerable 
interest because it reportedly accumulates hydrocarbon oils 
from 30 to 86% (1) of its dry weight and because these oils 
are considered progenitors to oil and coal shale deposits 
(2-4). While all B. braunii are morphologically similar, three 
65 distinct chemotypes of B. braunii have been reported 
depending on the type of hydrocarbons each accumulates 
(5). Race A accumulates fatty acid-derived alkadienes and 
US 9,487,762 Bl 
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While the unique mechanisms for C30 botryococcene and 
squalene biosynthesis in Botryococcus braunii have been 
elucidated (17), the specific mechanism(s) by which these 
triterpenes are methylated was unclear at the start of this 
work. Small molecule methylation has been extensively 
characterized for many diverse compounds and typically 
consists of a methyltransferase (MT) that utilizes the uni-
versal methyl-donor S-adenosyl methionine (SAM), and 
exhibits variable degrees of selectivity for a wide range of 
alkatrienes (6); race L accumulates the tetraterpene lycopa-
diene (7); and race B amasses the linear triterpenes, botryo-
coccene, squalene, and their methylated derivatives (8). Di-
and tetra-methylated botryococcenes are generally the most 
abundant oils accumulating in race B (9). However, lower 
amounts of tetramethylated-squalene (10) and variable 
amounts of other structural derivatives of botryococcene 
ranging from C31 to C37 accumulate to various levels in 
different race B strains and in response to variable culture 
conditions (9,11). The oils accumulate both in intracellular 
oil bodies and in association with an extracellular matrix 
(12), which in race B consists mainly of long-chain, cross-
linked polyacetals formed in large part from acetalization of 
polymethylsqualene dials that account for approximately 
10% of the dry weight (13). Other polymethylsqualene 
derivatives have been described in race B, such as diepoxy-
tetramethylsqualene (14), botryolins (15), and braunixan-
thins (16). The linear triterpenes, botryococcene, squalene, 
and their methylated derivatives, are hence common com-
ponents of B. braunii race B and make up a large proportion 
of its total biomass. 
10 methyl acceptor molecules (24). MTs are also distinguished 
as C-, 0-, N-, S- or halide methyltransferases, an indication 
of the methylation target within the acceptor substrate. 
While MTs may only share limited overall amino acid 
sequence similarities, domains responsible for SAM binding 
15 appear to be broadly conserved and highly conserved struc-
tural folds have served to associate MTs into five distinct 
Classes. Most of the small molecule MTs fall into Class 1, 
but do not appear to cluster phylogenetically based on their 
target site (i.e. methylation of carbon versus nitrogen) or the 
20 particular chemical class of the methyl acceptor substrate. 
An indole alkaloid MT, for instance, shows closer sequence 
similarity to a tocopherol MT rather than any other alkaloid 
specific MTs. Clustering in this instance appears more 
related to the evolutionary origins of the MTs and the 
A unique mechanism for botryococcene biosynthesis was 
recently described by Niehaus et a!. (17), in which two 
squalene synthase-like (SSL) enzymes perform the succes-
sive half-reactions that are normally catalyzed by a single 
enzyme in the case of squalene synthase. SSL-1 uses farne-
25 propensity of MTs to undergo neofunctionalization. There 
remains a need in the art to harness the unique oil biosyn-
thesis capacity for use in a system that allows for rapid and 
higher yield production. 
syl diphosphate (FPP) as a substrate to catalyze the produc-
tion of pre-squalene diphosphate (PSPP), which a second 
enzyme, SSL-3, converts to botryococcene in an NADPH-
dependent manner. A third enzyme, SSL-2, catalyzes the 
biosynthesis of squalene from PSPP produced by SSL-1 but 
cannot efficiently use FPP as a substrate. Overall, it was 
suggested that the squalene and botryococcene produced by 
the SSL enzymes were channeled into the production of the 
liquid oils and the biosynthesis of squalene derivatives, such 35 
as the extracellular matrix (17), while the conventional B. 
braunii squalene synthase (18) appears to synthesize 
squalene destined for sterol biosynthesis. 
There remains a need in the art to harness this unique oil 
30 biosynthetic capacity for use in a system that allows for 
more rapid and higher yield production. 
It is not botryococcene and squalene, however, that accu-
mulate to substantial levels in this algae, but the methylated 40 
forms of these triterpenes. For instance, while the liquid oil 
content of B. braunii race B is composed primarily of 
botryococcenes, generally less than 1% is in the non-
methylated C30 form and the majority is dominated by 
di-methylated and tetramethylated forms, depending on the 45 
strain and culture conditions (9, Metzger, 1983 #102,11). 
Essentially all the squalene that accumulates is in methyl-
ated forms, accumulating in the oil fraction (less than 5% of 
the total oil (19) or incorporated into a variety of other B. 
braunii natural products (13-16). Because B. braunii race B 50 
accumulates 30% or more of its dry weight as these triter-
pene components, one can estimate that the methylated 
triterpenes can account for up to 25% of the total algal 
biomass dry weight and contribute directly to the buoyancy 
that distinguishes these algal colonies. Unlike many green 55 
algae that are flagellated and phototaxic (20), the buoyance 
characteristic of Botryococcus provides a means for it to 
float in its normal aqueous habitats and to intercept a greater 
amount of photosynthetic light. In addition to these pur-
ported physiological roles, the methylated forms of botryo- 60 
coccene and squalene enhance their utility as feedstocks for 
petrochemical processing and chemical manufacturing. The 
increased branching evident in the methylated triterpenes 
improves their hydrocracking to chemical species of value 
for the synthesis of industrial polymers and other commod- 65 
ity based chemicals (21) and yields high quality gasoline, 
kerosene and diesel fuels upon distillation (22). 
SUMMARY OF THE INVENTION 
The presently-disclosed subject matter meets some or all 
of the above-identified needs, as will be evident to those of 
ordinary skill in the art after a study of information provided 
in this document. 
This disclosure describes several embodiments of the 
presently-disclosed subject matter, and in many cases lists 
variations and permutations of these embodiments. Accord-
ingly, this disclosure is merely exemplary of the numerous 
and varied embodiments. Mention of one or more represen-
tative features of a given embodiment is likewise exemplary. 
Such an embodiment can typically exist with or without the 
feature(s) mentioned; likewise, those features can be applied 
to other embodiments of the presently-disclosed subject 
matter, whether listed in this Summary or not. To avoid 
excessive repetition, this disclosure does not list or suggest 
all possible combinations of such features. 
The presently-disclosed subject matter relates to triter-
pene production, including methylated triterpene produc-
tion. In various forms, the subject matter relates to isolated 
nucleic acid sequences which encode various proteins 
including enzymes for the production of triterpenes and 
including methylated e.g. mono and di-methlyated triter-
penes. The presently-disclosed subject matter includes iso-
lated nucleic acids encoding triterpene methyltransferases, 
genetically modified or engineered triterpene methyltrans-
ferase having a chloroplast tag directing the triterpene 
methyltransferase to chloroplasts of plant cells when the 
protein is expressed in plant cells, expression vectors 
expressing a nucleic acid encoding triterpene methyltrans-
ferases, genetically modified cells, e.g. plant cells having an 
expression vector encoding one or more triterpene methyl-
transferases and methods for transforming cells with an 
expression vector encoding triterpene methyltransferases. 
US 9,487,762 Bl 
5 
In addition, the presently-disclosed subject matter is 
directed to exploiting the MEP pathway of plant cells to 
produce triterpenes and in particular methylated triterpenes. 
Using isolated nucleic acids, e.g. expression vectors with 
nucleic acid sequences encoding specific enzymes which 
target the products of the MEP pathway in chloroplast, 
methylated triterpenes are produced. For example, plant 
cells can be genetically modified to express various triter-
pene methyltransferases along with triterpene synthases 
(e.g. squalene synthase and/or botryococcene synthase and 10 
prenyltransferase (PT)), all with addressing information 
(e.g. tags) such that the encoded enzymes are directed to the 
chloroplast compartment of the transfected plant cells. As a 
result, the presently engineered mechanism provides a 
unique metabolism incorporated in a non-native environ- 15 
ment within plant cells. From the present design, triterpene 
biosynthesis can occur in the chloroplast compartment in a 
manner such that carbon from the MEP pathway can be 
diverted to triterpene biosynthesis. An advantage of this 
scheme or approach is to eliminate regulatory mechanisms 20 
controlling triterpene biosynthesis which occurs in the cyto-
plasm and hence the present scheme provides a robust 
production level oftriterpenes. In various alternative forms, 
the triterpene synthase can include one or more combina-
tions of synthases other than squalene and botryococcene 25 
synthases. 
The present invention, in one form thereof, relates to an 
isolated nucleic acid having a nucleic acid sequence encod-
ing at least one protein selected from the group consisting of 
triterpene methyltransferase 1 (TMT-1), triterpene methyl- 30 
transferase 2 (TMT-2) and triterpene methyltransferase 3 
(TMT-3). In one further embodiment, the nucleic acid 
sequence encodes at least two proteins selected from the 
group consisting of TMT-1, TMT-2 and TMT-3 or alterna-
tively all three proteins. The nucleic acid sequence may be 35 
selected from the group consisting of SEQ ID NOS: 1, 2 and 
3. 
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further specific form, the expression vector includes a 
sequence encoding at least one triterpene synthase such as 
squalene synthase or botryococcene synthase or both. In one 
form, the triterpene synthases may be from B. braunii. In yet 
a further specific form, the nucleic acid may also have a 
sequence encoding prenyltransferase. 
In yet an alternative, further form, the expression vector 
may include one or more chloroplast target sequences 
wherein when the expression vector is used to transform a 
plant cell and the nucleic acid is expressed in the plant cell, 
one or more proteins encoded by the expression vector are 
directed to a chloroplast. 
The present invention, in another form thereof, relates to 
a transfected plant cell with an expression vector comprising 
a nucleic acid having a nucleic acid sequence encoding a 
protein selected from the group consisting of triterpene 
methyltransferase 1, triterpene methyltransferase 2 and trit-
erpene methyltransferase 3. In various further advantageous 
forms, the expression vector further includes genes for 
triterpene synthase such as squalene synthase and/or botryo-
coccene synthase. In yet a further form, the nucleic acid 
further includes a sequence encoding prenyltransferase. In a 
still further form, one or more of the triterpene methyltrans-
ferases, triterpene synthases and prenyltransferase include a 
sequence targeting these proteins to the chloroplasts of the 
plant cell. 
The present invention, in yet another form thereof relates 
to a method for transforming a cell which includes trans-
fecting a plant cell with an expression vector comprising a 
nucleic acid having a nucleic acid sequence encoding one or 
more protein sequences selected from the group consisting 
ofTMT-1, TMT-2 and TMT-3. In various further form, the 
expression vector may further include nucleic acid 
sequences for encoding one or more triterpene synthases and 
prenyltransferase. Advantageously, the proteins include a 
tag or address which directs the enzymes to the chloroplast 
compartment of the transfected plant cell. 
The presently-disclosed subject matter relates to methyl-
ation of a triterpene analogs of squalene and botryococcene 
using different methyltransferases. 
In one advantageous form, the isolated nucleic acid may 
include non-native nucleic acid sequences ofTMT-1, TMT-2 
and TMT-3. As used throughout this disclosure, non-native 40 
nucleic acid sequences include nucleic acids sequences 
which are not found in the native forms of the nucleic acid 
sequences, i.e. sequences that are not found in nature or 
naturally occurring with genes for encoding triterpene meth-
yltransferases. These non-native (to triterpene methyltrans-
ferases) nucleic acid sequences may occur at the 5' end, 3' 
end or within the sequence of the nucleic acid sequences 
encoding TMT-1, TMT-2 and TMT-3. 
Further, the present-disclosed subject matter relates to 
mechanisms for the biosynthesis of botryococcene and 
45 squalene analogs using specific enzymes responsible for 
decorating these triterpene scaffolds with methyl substitutes. 
In yet another alternative form, the isolated nucleic acid 
may include a chloroplast target sequence, wherein when the 
nucleic acid is expressed in a plant cell with chloroplasts, the 
protein is directed to the chloroplasts. 
In addition, the present-disclosed subject matter relates to 
genetically engineered or transgenic yeast and plants which 
have triterpene methyltransferase (TMTs) which provide 
50 methylation of a side chain of sterols. 
The present invention, in another form thereof, relates to 
Further, the present subject matter relates to genetically 
engineered yeast which has been modified to specifically 
express methyltransferase-like genes including yeast which 
have been transformed to co-express complimentary 
55 squalene synthase or botryococcene synthase. 
a non-naturally occurring protein in the form of a triterpene 
methyltransferase with a chloroplast tag wherein, the triter-
pene methyltransferase is directed to chloroplasts of plant 
cells when the protein is synthesized in the plant cells. In 
various further specific advantageous forms, the triterpene 
methyltransferase may be TMT-1, TMT-2 and/or TMT-3. 
The protein may have an amino acid sequence encoded from 60 
a nucleic acid having a nucleic acid sequence selected from 
the group consisting of SEQ ID NOS: 1-3. 
The present invention in another form thereof relates to an 
expression vector comprising a nucleic acid having a nucleic 
acid sequence encoding a protein selected from the group 65 
consisting of triterpene methy !transferase 1, triterpene meth-
yltransferase 2 and triterpene methyltransferase 3. In one 
In addition, the present subject matter relates to the use of 
TMT-1 and TMT-2 for methylation of squalene and TMT-3 
for the methylation of botryococcene. 
BRIEF DESCRIPTION OF THE DRAWINGS 
FIG. 1 is a schematic illustrating the mevalonate (MVA) 
pathway in cytoplasm of wild type cells (left side) and the 
methyl erythritol phosphate (MEP) pathway of plant chlo-
roplast (right side). 
FIG. 2 is a graph showing triterpene content in accordance 
with the present invention. 
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FIG. 3 is chart illustrating triterpene chemical profiles of 
plants engineered for methylated botryococcene and 
squalene biosynthesis in accordance with the present inven-
tion. 
FIG. 4 shows amino acid aligmnent of six sterol C-24 5 
methyltransferases-like genes from B. braunii race B along 
with those of C. reinhardtii (EDP05221) and A. thaliana 
(AAG28462) identified as SEQ ID NOS: 7-14. Conserved 
sterol-binding domains (SMT) and S-adenosyl methionine-
binding domains (SAM) as identified by (27) are boxed and 10 
labeled in blue or red, respectively. 
FIG. 5 is a graph providing a functional characterization 
of B. braunii race B TMT genes. Yeast expressing various 
combinations of triterpene synthase and TMTs were grown 15 
in shake flask for five days and organic extracts analyzed by 
GC-MS (chromatograms shown). TMT genes were co-
expressed with BSS (squalene synthase) [TMT-1 (D), 
TMT-2 (E), and TMT-3 (F)], or SSL-1-3m (botryococcene 
synthase) [TMT-1 (G), TMT-2 (H), and TMT-3 (I)]. Yeast 20 
expressing only BSS (B) or SSL-1-3m (C) or only harboring 
empty expression vectors (A) serve as background controls. 
The chromatograms are am10tated for the elution behavior of 
C30-botryococcene (1), C31-botryococcene (2), C32-
botryococcene (3), squalene (4), C31-squalene (5), and 25 
C32-squalene (6). 
FIG. 6 consists of graphs (A)-(F) showing accumulation 
of triterpenes in yeast engineered with various triterpene 
synthases and triterpene methyltransferases (TMT's). Yeast 
were engineered with B. braunii squalene synthase (BSS) 30 
and either TMT-1 (A), TMT-2 (B), or TMT-3 (C) on separate 
plasmids and accumulation of squalene (closed circles), C31 
squalene (closed squares), and C32 squalene (closed tri-
angles) measured, or with the botryococcene SSL-1-3m and 
8 
mono- or di-methyl squalene, while TMT-3 acts on C30 
botryococcene to form mono- or dimethyl botryococcene. 
FIG. 9 comprises two graphs in panels (A) and (B) 
showing the accumulation oftriterpenes in yeast engineered 
with various triterpene synthases in accordance with the 
present invention. Yeast line TN-7 was engineered with 
either B. braunii squalene synthase (panel A, left side) or 
SSL-1-3m (panel B, right side) and accumulation of 
squalene (squares), or botryococcene (triangles) measured. 
Yeast were grown in selection media in shake flasks at 30° 
C. for the indicated time and organic extracts analyzed by 
GC-MS. Data represents mean±S.E.M. 
FIG. 10 shows mass spectra ofC31 squalene (A) and C32 
squalene (B) produced in TN7 yeast expressing BSS and 
TMT-1, TMT-2 or TMT-3, C31 botryococcene (C) produced 
in TN7 yeast expressing SSL-1-3m and TMT-1, TMT-2 or 
TMT-3, and C32 botryococcene (D) produced in TN7 yeast 
expressing SSL-1-3m and TMT-3. 
DETAILED DESCRIPTION 
The details of one or more embodiments of the presently-
disclosed subject matter are set forth in this disclosure. 
Modifications to embodiments described in this document, 
and other embodiments, will be evident to those of ordinary 
skill in the art after a study of the information provided in 
this document. The information provided in this document, 
and particularly the specific details of the described exem-
plary embodiments, is provided primarily for clearness of 
understanding and no unnecessary limitations are to be 
understood therefrom. In case of conflict, the specification of 
this document, including definitions, will control. 
Some of the polynucleotide and polypeptide sequences 
disclosed herein are cross-referenced to GENBANK®/ 
either TMT-1 (D), TMT-2 (E), or TMT-3 (F) on separate 35 GENPEPT® accession numbers. The sequences cross-ref-
plasmids and accumulation of C30 botryococcene (open erenced in the GENBANK®/GENPEPT® database are 
circles), C31 botryococcene (open squares), and C32 botryo-
coccene (open triangles) measured. Yeast was grown in 
shake flasks at 30° C. for the indicated time and organic 
extracts analyzed by GC-MS. Data represents mean±S.E.M 40 
of 3 replicates. 
expressly incorporated by reference as are equivalent and 
related sequences present in GENBANK®/GENPEPT® or 
other public databases. Also expressly incorporated herein 
by reference are all annotations present in the GENBANK®/ 
GENPEPT® database associated with the sequences dis-
closed herein. Unless otherwise indicated or apparent, the 
references to the GENBANK®/GENPEPT® database are 
FIG. 7 shows the structures of the various triterpenes 
(compounds 1-7) accumulating in yeast expressing squalene 
synthase or botryococcene synthase in combination with 
TMT-1, -2 or -3 in accordance with the present invention. 
Yeast expressing the squalene synthase (BSS) gene accu-
mulates squalene (1), and C31 mono-methylated squalene 
references to the most recent version of the database as of 
45 the filing date of this Application. 
(2) and C32 di-methylated squalene (3) when co-expressed 
with the TMT-1, TMT-2, or TMT-3 genes. Yeast expressing 
the botryococcene synthase expression cassette (SSL-1-3m) 50 
accumulates C30 botryococcene ( 4), but a mixture of C31 
mono-methylated isomers, showacene (5) and isoshowacene 
(6), and C32 di-methylated botryococcene (7) when co-
expressed with TMT-3. Squalene and botryococcene have 
their carbons labeled, and the common sites of methylation 55 
are indicated with red arrows. The mono- and di-methylation 
sites with the triterpenes that accumulate in the respective 
yeast lines are highlighted with red circles. Methylation sites 
were assigned according to NMR signatures of the isolated 
compounds (Table S1) with reference to those previous 60 
reported (16, 20, 31, 34, 35). 
FIG. 8 is a scheme showing the methyl triterpene biosyn-
thetic pathways in B. braunii. SSL-1 converts two FPP 
molecules to PSPP, which is converted in an NADPH-
dependent mam1er to either squalene or C30 botryococcene 65 
by SSL-2 or SSL-3, respectively. TMT-1 and TMT-2 can 
transfer a methyl group from SAM to squalene to form 
While the terms used herein are believed to be well 
understood by one of ordinary skill in the art, definitions are 
set forth to facilitate explanation of the presently-disclosed 
subject matter. 
Unless defined otherwise, all technical and scientific 
terms used herein have the same meaning as commonly 
understood by one of ordinary skill in the art to which the 
presently-disclosed subject matter belongs. Although any 
methods, devices, and materials similar or equivalent to 
those described herein can be used in the practice or testing 
of the presently-disclosed subject matter, representative 
methods, devices, and materials are now described. 
Following long-standing patent law convention, the terms 
"a", "an", and "the" refer to "one or more" when used in this 
application, including the claims. Thus, for example, refer-
ence to "a cell" includes a plurality of such cells, and so 
forth. 
Unless otherwise indicated, all numbers expressing quan-
tities of ingredients, properties such as reaction conditions, 
and so forth used in the specification and claims are to be 
understood as being modified in all instances by the term 
"about". Accordingly, unless indicated to the contrary, the 
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numerical parameters set forth in this specification and 
claims are approximations that can vary depending upon the 
desired properties sought to be obtained by the presently-
disclosed subject matter. 
As used herein, the term "about," when referring to a 
value or to an amount of mass, weight, time, volume, 
concentration or percentage is meant to encompass varia-
tions of in some embodiments ±20%, in some embodiments 
±10%, in some embodiments ±5%, in some embodiments 
±1%, in some embodiments ±0.5%, and in some embodi-
ments ±0.1% from the specified amount, as such variations 
are appropriate to perform the disclosed method. By way of 
providing an example, about 60% is inclusive of: 
60%±0.1%, which is inclusive of 59.9%-60.1%, and so 
forth. 
As used herein, ranges can be expressed as from "about" 
one particular value, and/or to "about" another particular 
value. It is also understood that there are a number of values 
disclosed herein, and that each value is also herein disclosed 
as "about" that particular value in addition to the value itself. 
For example, if the value "10" is disclosed, then "about 10" 
is also disclosed. It is also understood that each unit between 
10 
polypeptide) are an implied feature of every nucleic acid 
sequence which encodes an amino acid. 
It will be appreciated by those skilled in the art that due 
to the degeneracy of the genetic code, a multitude of 
nucleotide sequences encoding modified triterpene synthase 
polypeptides of the presently-disclosed subject matter may 
be produced, some of which bear substantial identity to the 
nucleic acid sequences explicitly disclosed herein. For 
instance, codons AGA, AGG, CGA, CGC, CGG, and CGU 
10 all encode the amino acid arginine. Thus, at every position 
in the nucleic acid molecules of the presently-disclosed 
subject matter where an arginine is specified by a codon, the 
codon can be altered to any of the corresponding codons 
described above without altering the encoded polypeptide. It 
15 is understood that U in an RNA sequence corresponds to T 
in a DNA sequence. 
A polynucleotide, polypeptide, or other component is 
"isolated" when it is partially or completely separated from 
components with which it is normally associated (other 
20 proteins, nucleic acid molecules, cells, synthetic reagents, 
etc.). A nucleic acid molecule or polypeptide is "recombi-
nant" when it is artificial or engineered, or derived from an 
artificial or engineered protein or nucleic acid molecule. For 
two particular units are also disclosed. For example, if 10 
and 15 are disclosed, then 11, 12, 13, and 14 are also 25 
disclosed. 
example, a polynucleotide that is inserted into a vector or 
any other heterologous location, e.g., in a genome of a 
recombinant organism, such that it is not associated with 
A "parent" protein, enzyme, polynucleotide, gene, or cell, 
is any protein, enzyme, polynucleotide, gene, or cell, from 
which any other protein, enzyme, polynucleotide, gene, or 
cell, is derived or made, using any methods, tools or 
techniques, and whether or not the parent is itself native or 
mutant. A parent polynucleotide or gene encodes for a parent 
protein or enzyme. 
A "mutation" means any process or mechanism resulting 
in a mutant protein, enzyme, polynucleotide, gene, or cell. 
This includes any mutation in which a protein, enzyme, 
polynucleotide, or gene sequence is altered, and any detect-
able change in a cell arising from such a mutation. Typically, 
a mutation occurs in a polynucleotide or gene sequence, by 
point mutations, deletions, or insertions of single or multiple 
nucleotide residues. A mutation includes polynucleotide 
alterations arising within a protein-encoding region of a 
gene as well as alterations in regions outside of a protein-
encoding sequence, such as, but not limited to, regulatory or 
promoter sequences. A mutation in a gene can be "silent", 
i.e., not reflected in an amino acid alteration upon expres-
sion, leading to a "sequence-conservative" variant of the 
gene. This generally arises because of degeneracy of the 
genetic code wherein more than one codon codes for the 
same amino acid. 
It is understood that the addition of sequences that do not 
alter the encoded activity of a nucleic acid molecule, such as 
the addition of a non-functional or non-coding sequence, is 
nucleotide sequences that normally flank the polynucleotide 
as it is found in nature is a recombinant polynucleotide. A 
protein expressed in vitro or in vivo from a recombinant 
30 polynucleotide is an example of a recombinant polypeptide. 
Likewise, a polynucleotide sequence that does not appear in 
nature, for example a variant of a naturally occurring gene, 
is recombinant. For example, an "isolated" nucleic acid 
molecule is one which is separated from other nucleic acid 
35 molecules which are present in the natural source of the 
nucleic acid molecule. For example, with regards to 
genomic DNA, the term "isolated" includes nucleic acid 
molecules which are separated from the chromosome with 
which the genomic DNA is naturally associated. Typically, 
40 an "isolated" nucleic acid molecule is free of sequences 
which naturally flank the nucleic acid molecule (i.e., 
sequences located at the 5' and 3' ends of the nucleic acid 
molecule) in the genomic DNA of the organism from which 
the nucleic acid molecule is derived. For example, in various 
45 embodiments, the isolated nucleic acid molecule can contain 
less than about 5 kb, 4 kb, 3 kb, 2 kb, 1 kb, 0.5 kb or 0.1 kb 
of nucleotide sequences which naturally flank the nucleic 
acid molecule in genomic DNA of the cell from which the 
nucleic acid molecule is derived. Moreover, an "isolated" 
50 nucleic acid molecule, such as a eDNA molecule, can be 
substantially free of other cellular material, or culture 
medium when produced by recombinant techniques, or 
substantially free of chemical precursors or other chemicals 
a conservative variation of the basic nucleic acid molecule. 
The "activity" of an enzyme is a measure of its ability to 55 
catalyze a reaction, i.e., to "function", and may be expressed 
when chemically synthesized. 
The presently-disclosed invention is based on the con-
ventional beliefs that botryococcene biosynthesis resembles 
that of squalene, a metabolite essential for sterol metabolism 
in all enkaryotes. Squalene arises from an initial condensa-
tion of two molecules offarnesyl diphosphate (FPP) to form 
as the rate at which the product of the reaction is produced. 
For example, enzyme activity can be represented as the 
amount of product produced per unit of time or per unit of 
enzyme (e.g., concentration or weight), or in terms of affinity 
or dissociation constants. 
One of skill in the art will appreciate that many conser-
vative substitutions of the nucleic acid constructs which are 
disclosed herein yield a functionally identical construct. For 
example, owing to the degeneracy of the genetic code, 
"silent substitutions" (i.e., substitutions in a nucleic acid 
sequence which do not result in an alteration in an encoded 
60 pre-squalene diphosphate (PSPP), which then undergoes a 
reductive rearrangement to form squalene. In principle, 
botryococcene could arise from an alternative rearrange-
ment of the pre-squalene intermediate. Because of these 
proposed similarities, the present inventors believe that a 
65 botryococcene synthase would resemble squalene synthase 
and hence isolated squalene synthase-like genes from B. 
braunii race B. While B. braunii does harbor at least one 
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typical squalene synthase, none of the other three squalene 
synthase-like (SSL) genes encode for botryococcene bio-
synthesis directly. SSL-1 catalyzes the biosynthesis ofPSPP 
and SSL-2 the biosynthesis ofbisfamesyl ether, while SSL-3 
does not appear able to directly utilize FPP as a substrate. 
However, when combinations of the synthase-like enzymes 
were mixed together, in vivo and in vitro, robust botryococ-
cene (SSL-1+SSL-3) or squalene biosynthesis (SSLl+SSL-
2) was observed. These findings were unexpected because 
squalene synthase, an ancient and likely progenitor to the 10 
other Botryococcus triterpene synthases, catalyzes a two-
step reaction within a single enzyme unit without interme-
diate release, yet in B. braunii, these activities appear to 
have separated and evolved inter-dependently for special-
ized triterpene oil production greater than 500 MYA. Co- 15 
expression of the SSL-1 and SSL-3 genes in different 
configurations, as independent genes, as gene fusions, or 
targeted to intracellular membranes, also demonstrate the 
potential for engineering even greater efficiencies ofbotryo-
coccene biosynthesis. 20 
The present system and method will now be described 
with regard to various experiments and examples which 
provide for additional understanding of the present method 
and system. 
Transgenic plants were created using conventional trans- 25 
formation technology in order to produce transgenic plants 
which produce triterpenes using the MEP pathway in the 
chloroplast of the plant cells. The transgenic plants success-
fully express triterpene methyltransferases in combination 
with appropriate triterpene synthases, producing mono- and 30 
di-methylated forms of squalene and botryococcene. As a 
result, the transgenic plants introduce triterpenes biosynthe-
sis in the chloroplast compartment in a manner such that the 
carbon from the MEP pathway is diverted to triterpene 
biosynthesis. Advantageously, this approach eliminates 35 
regulatory mechanisms controlling triterpenes biosynthesis 
in the cytoplasm, hence providing a robust production level 
oftriterpenes. For exemplary purposes, reference is made to 
FIG. 1, right side depicting the MEP pathway in chloroplast. 
The transgenic plants have been transfected by the intra- 40 
duction of genes for prenyltransferase (PT) specific triter-
pene synthases (e.g. squalene synthase and/or botryococ-
cene synthase) and various triterpene methyltransferases 
into the nuclear genome of the plant cells along with 
addressing information such that the encoded enzymes are 45 
directed to the chloroplast compartment of the transgenic 
plants. 
The transgenic plants were created using conventional 
transformation technology. Gene constructs (FIG. 3) were 
generated, introduced into Agrobacterium tumefaciens and 50 
sterile leaf explants where then inoculated with the respec-
tive A. tumefaciens cultures. Because the gene constructs 
harbor an antibiotic resistance gene, plant cells transformed 
with the various gene constructs can be selected and regen-
erated into intact, individual plants to yield independent 55 
transgenic plant lines. The respective plant lines are then 
propagated in a greenhouse and leaf discs of 1.5 em har-
vested in order to extract and profile their triterpenes content 
by GC-MS (as described previous). In brief, the leaf discs 
are powdered in liquid nitrogen, the powdered tissue 60 
extracted with a 2-3 ml hexane per gm powdered tissue, and 
the hexane extract clarified by passing it over a silica column 
(0.5 em by 2 em). The colunm flow-through is then evalu-
ated by standard GC-MS as illustrated in FIG. 2. 
FIG. 2 illustrates examples of GC-MS analysis of trans- 65 
genic plant material for triterpenes content. The upper panel 
is the analysis of a plant engineered for only squalene 
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production in the chloroplast compartment and was demon-
strated to accumulate high levels of squalene (peak #1, 
verified by authentic standards and MS match). This same 
transgenic plant line was then engineered separately with a 
gene encoding for triterpene methyl transferase 1 (TMT-1) or 
2 (TMT-2), the transgenic plants harboring all the trans genes 
regenerated and profiled by GC-MS. The peaks correspond-
ing to peaks 2 and 3 correspond to monomethylated (2) and 
dimethylated (3) squalene. An analogous strategy was used 
to create plant lines accumulating botryococcene produced 
in the chloroplast, and those high accumulating lines were 
then engineered with triterpene methyltransferases genes 1, 
2 and 3. For the botryococcene engineered lines, only those 
plant harboring the TMT3 gene accumulated mono- and 
di-methylated forms of botryococcene. In contrast, for the 
squalene engineered plants, only those subsequently engi-
neered with TMT-1 and 2 accumulated mono- and di-
methylated forms of squalene. 
FIG. 3 illustrates the analysis of transgenic plant lines (#) 
for their triterpenes contents. The upper panel is specific for 
those plants engineered for botryococcene and methylated 
botryococcene biosynthesis in the cytoplasm versus the 
chloroplast compartment. For example, the first three trans-
genic lines evaluate (#1, 10 and 15) were all engineered for 
the botryococcene biosynthesis in the chloroplast (as noted 
by the tp designation), but the triterpene methyltransferase 
was targeted to the cytoplasm (no tp designation). Expres-
sion of both gene constructs were derived by strong consti-
tutive promoter (either the cauliflower mosaic virus 35 S 
promoter, Pea; or the corresponding cassava mosaic virus 
promoter, Pcv). The green histogram bars represent the 
amount of botryococcene accumulation, while the yellow 
and red bars represent the amount of mono- and di-methyl-
ated botryococcene, respectively. Only when both the 
botryococcene synthase and triterpene methyltransferase are 
targeted to the chloroplast compartment is there significant 
triterpenes accumulation and significant amounts of meth-
ylated botryococcene observed. The constructs with the 
botryococcene targeted to the chloroplast compartment and 
with a carboxy-terminal sequence to direct the BS enzyme 
to the membrane within the chloroplast (tp-BS-mp ), did not 
yield more botryococcene, but the relative conversion of the 
botryococcene to its methylated forms was much greater. 
FIG. 3 shows an illustration of triterpene chemical pro-
files of plants engineered for methylated botryococcene and 
squalene biosynthesis. The lower panel (or half) of FIG. 3 
illustrates the same chemical analysis for plants engineered 
for squalene and methylated squalene production. For 
example, plants #7, 14, and 21 were engineered for squalene 
biosynthesis in the chloroplast compartment (tp designa-
tion), but triterpenes methyltransferase enzymes 1 and 2 
were targeted to the cytosoloic compartment (no tp desig-
nation). These plants clearly accumulate high levels of 
squalene and very little methylated forms. In contrast, when 
both the squalene synthase and methyltransferase genes are 
targeted to the chloroplast compartment (tp designations), 
high levels of mono- and di-methylated forms of squalene 
accumulate. 
It is important to note that only squalene accumulating 
plants engineered with triterpene methyltransferase 1 and 2, 
but not TMT-3, accumulate methylated squalene. In con-
trast, only botryococcene accumulating plants engineered 
with TMT-3, but not TMT-1 or 2, accumulated methylate 
botryococcene. This is a demonstration that each methyl-
transferase exhibits substrate specificity for either squalene 
or botryococcene. 
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for the methyltransferase genes. Individual colonies were 
subsequently grown in 30 ml of the appropriate Yeast 
Synthetic Drop-out medium (selection) containing 5 mg/1 
ergosterol for the indicated time at 30° C. before analyzing 
the cultures for production of novel triterpene components. 
In brief, 1 ml aliquots of the culture were combined with 
1 ml of acetone, mixed vigorously, and incubated at room 
temperature for 10 min. One ml of hexane was added and 
mixed vigorously for 60 sec. The mixture was then centri-
In an alternative forms or embodiments, transgenic plants 
are generated using isolated nucleic acid such as expression 
vectors having nucleic acid sequences encoding various 
triterpene methyltransferases including ones with tags 
directing the enzyme( s) to the chloroplast of the transgenic 5 
plant cells. Further, the expression vector can include other 
enzymes for triterpene biosynthesis using the MEP pathway 
which include one or more triterpene synthases such as 
squalene synthase or botryococcene synthase and prenyl-
transferase. 10 fuged briefly at 500 g to separate the phases, and an aliquot 
of the organic phase (1-3 fll) analyzed by GC-MS with a 
Varian CP-3800 GC coupled to a Varian Saturn 2200 
MS/MS (Varian Medical Systems) using a Supelco SLB-5 
Exemplar Experimental Procedures 
The following exemplar experimental procedures provide 
a better understanding of the presently disclosed subject 
matter including method and procedures for producing vari-
ous transgenic cells, isolated nucleic acid sequences and 15 
expression vectors for the production of triterpenes. 
Cloning the SMT-Like Genes-
The triterpene methyltransferase-3 (TMT-3) identified 
through a random sequencing effort of ESTs using a B. 
braunii phage eDNA library as previously described (17). 20 
Briefly, phages were converted to their plasmid form using 
the mass excision protocol as described by the manufacturer 
(Stratagene), and -500 individual colonies were randomly 
selected for automated DNA sequencing using sequencing 
primers flanking the eDNA insertion sites. Manually 25 
assembled eDNA sequences were then screened against the 
NCBI tB!astn search function across all available databases 
and TMT-3 was identified as exhibiting similarity to C-24-
sterol methyltransferase (SMT) genes. All other SMT-like 
genes were identified in a B. braunii 454 transcriptomic 30 
dataset as previously described (17). This dataset was 
screened computationally using a NCBI BLAST search 
window with the C. reinhardtii SMT-1 protein sequence 
(EDP05221) and theArabidopsis thaliana SMT-1 sequence 
(AAG28462) as the queries, which led to the identification 35 
of six full-length ORFs that were at least 42% identical and 
59% similar to C. reinhardtii SMT. Full sequence data is 
available from Genbank. Full sequence data is available 
from Genbank (TMT-1, JN828962; TMT-2 JN828963; 
TMT-3, JN828964; SMT-1, JN828965; SMT-2, JN828966; 40 
SMT-3, JN828967). 
Primers flanked by the BamHI and Notl or EcoRI and 
Notl restriction enzyme sites were designed to amplify each 
of the six SMT-like genes from Botryococcus braunii 
mRNA, the amplification products digested with the corre- 45 
sponding restriction enzymes, then ligated into the standard 
yeast expression vectors YEp352-Ura or pESC-Leu (17). All 
constructs were verified by DNA sequencing. 
Yeast Expression Studies-
Yeast lines previously developed for high level accumu- 50 
lation of squalene and botryococcene were used for evalu-
ating the putative triterpene methyltransferase genes (17,23, 
24). These lines consist of the TN7 parental strain harboring 
an insertional mutation in the native yeast squalene synthase 
gene (ERG9) transformed with expression vectors contain- 55 
ing either the full-length Botryococcus squalene synthase 
(BSS) gene (18) or a fusion of the Botryococcus SSL-1 and 
SSL-3 genes (functional equivalent of botryococcene syn-
thase) including a sequence encoding for the carboxy-
terminal membrane targeting domain of the Botryococcus 60 
squalene synthase protein (SSL-1-3m) (17). The various 
methyltransferase expression vectors were introduced into 
these two yeast lines using the lithium acetate transforma-
tion protocol, followed by selection for complementation of 
the uracil and leucine auxotrophic growth markers (24). 65 
Transformants were confirmed to possess the various 
expression vectors using colony PCR with primers selective 
ms fused silica capillary colunm (30 mx0.25 mmx0.25 flill 
film thickness, Supelco ). The initial oven temperature was 
set at 220° C. for 1 min., ramped to 280° C. at 20° C./min., 
then ramped to 298° C. at 3° C./min. 
Purification of Mono- and Di-Methylated Triterpenes-
Yeast lines containing the respective triterpene synthase 
and TMT expression cassettes were grown in 1 L Yeast 
Synthetic Drop-out medium media containing 5 mg/1 ergos-
terol at 28° C. for 8 days, after which hexane extracts were 
prepared. The crude extracts were then subject to HPLC 
separation on a Waters 2695 HPLC with a Waters 2996 
Photodiode Array detector (Waters Corporation) and a 
Develosil 60-3, 250 mmx20 mm colunm (Nomura Chemi-
cal), run in isocratic mode (100% n-hexane) at 8 ml/min. 
Under these conditions, C32 botrycooccene, C31 botryo-
coccene, C32 squalene, and C31 squalene eluted at -18, 22, 
32, and 34 minutes, respectively. Repetitive chromato-
graphic runs afforded further purification of the various 
compounds. 
NMR of methylated triterpenes-1H and 13C NMR spec-
tra were recorded on a JEOL alpha 600 NMR spectrometer 
at 300K. Chemical shifts were referenced relative to solvent 
peaks, namely dH 7.24 and de 77.1 for CDC13 . Each product 
was identified as shown in FIG. 7 by reference to 13C 
chemical shifts for botryococcenes and methylsqualenes 
previously reported (10,16,19,25,26). 
In Vitro Assays for the Methyltransferase Activities-
The various B. braunii SMT-like genes or empty vector 
control were expressed in TN-7 yeast and grown in 100 ml 
selection media for 3 days, after which microsomes were 
prepared according to the methods of Pompon et a!. (27). 
Enzyme assays contained 50 mM HEPES, pH 7.5, either 
0.01% (TMT-3) or 0.1% (all other samples) DHPC, 2 mM 
acceptor substrate (botryococcene, squalene, C32-botryo-
coccene, C32-squalene, cycloartenol, zymosterol, or lanos-
terol), 50 f.LM 3H-SAM (-150 dpm/pmole), 2 fll microsomes, 
in 100 fll total volume. Assays were set up by first combining 
everything except 3H-SAM and microsomes and treating 
with a sonicating water bath (Branson 2510) for -1 min. 
until the solution became cloudy due to micelle formation, 
after which 3H-SAM and microsomes were added and the 
reaction incubated at 37° C. for 5 min. Reactions were 
stopped by adding an equal volume of 10% (w/v) KOH in 
methanol, followed by extraction of hydrocarbon products 
with 400 fll n-hexane. An aliquot of the organic phase was 
spotted on silica TLC plates and developed with n-hexane: 
MTBE (25: 1 ). Triterpenes were visualized with iodine vapor 
and the corresponding zones were scraped and subject to 
scintillation analysis. 
Results 
Identification of Triterpene Methyltransferase Candidate 
Genes-
from experiments conducted one predicts that a methyl-
transferase acting on squalene or botryococcene would 
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resemble a C-24 sterol methyltransferase (SMT) because 
these enzymes act on the linear isoprenoid side chain of 
sterols. A B. braunii transcriptomic database (17) was 
screened computationally for cDNAs showing amino acid 
sequence similarities to the A. thaliana and C. reinhardtii 
SMT-1 enzymes. The BLAST search revealed six candidate 
genes that were greater than 42% identical and 59% similar 
to the C. reinhardtii SMT-1 (FIG. 4). For comparison, theA. 
thaliana genome contains three predicted SMT genes (28), 
and the C. reinhardtii genome contains only one SMT gene 
(29). These particular genes appear overrepresented in B. 
braunii compared to other plants and algae and enhanced the 
prospects these could be triterpene methyl-transferases 
(TMTs). Amino acid aligrnnents revealed that all six candi-
date genes share three conserved SAM binding sites as 
identified by Kagen and Clarke (28); however, the sterol 
binding domain SMT-2, which is invariant in all known 
plant SMTs (31, 32), is absolutely conserved in three of the 
candidates (SMT-1, -2, and -3), but not so in the other three 
(TMT-1, -2, and -3) (FIG. 4). In contrast to other sterol 
methyltransferases (31, 32), the B. braunii MTs possess 
distinct amino-terminal hydrophobic regions within the first 
50 amino acids indicative that these proteins might not 
behave as soluble proteins but rather might associate with 
membrane systems. 
In Vivo Functional Characterization of MT Activities-
To screen the six candidates for TMT capabilities, we 
co-expressed the various SMT-like genes in TN7 yeast 
engineered with either B. braunii squalene synthase (BSS) 
or a construct in which SSL-1 and SSL-3 are fused with a 
(GSGG)3 amino acid linker and also contains the 73 C-ter-
minal amino acids of BSS fused to its C-terminus (SSL-1-
3m). TN7 yeast engineered with BSS or SSL-1-3m can 
accumulate squalene or botryococcene, respectively, to lev-
16 
monomethy 1-botryococcene and no dimethy 1-botryococcene 
was detected (FIG. 5, row G, and FIG. 6, panel (D)). 
Similarly, when TMT-2 was co-expressed with BSS, 40% of 
squalenes accumulated as methyl-derivatives with 31% 
accumulating as monomethyl-squalene (FIG. 5, row E, and 
FIG. 6, panel (B)). Only 2% of total botryococcenes accu-
mulated as monomethyl-botryococcene when co-expressed 
with SSL-1-3m (FIG. 5, row Hand FIG. 6, panel (E)). When 
TMT-3 was co-expressed with BSS, approximately 18% of 
10 the total accumulating squalene was converted to its methyl-
derivatives, with 11% of that as monomethyl-squalene (FIG. 
5, row F and FIG. 6, panel (C)). When TMT-3 was co-
expressed with SSL-1-3m, 33% of the accumulating botryo-
coccene was methylated with greater than half of that in the 
15 dimethyl-botryococcene form (FIG. 5, row I and FIG. 6, 
panel (F)). 
While the conversion of botryococcene and squalene to 
their mono- and di-methyl derivatives were readily detected, 
no further methylated products (tri- and tetra-methylated) 
20 accumulated. In view of the forgoing it was believed that 
multiple methyltransferases might act successively and 
cooperatively in the formation of C34 triterpenes, with one 
methyl transferase catalyzing the C30 to C32 conversion and 
another using C32 as a substrate to form a C34 triterpene. To 
25 test this possibility, yeast expressing either BSS or SSL-1-
3m with TMT-1, TMT-2 or TMT-3 as well as one of the 
remaining five other SMT-like B. braunii genes were evalu-
ated for their triterpene content. No unique products other 
than the C31 and C32 triterpenes observed in the yeast lines 
30 expressing only TMT-1, -2 or -3 (FIG. 5) were detected by 
GC-MS analysis (data not shown). 
In Vitro Biochemical Confirmation-
els above 100 mg/L (FIG. 5 (row B, row C) and FIG. 9). 35 
When SMT-1, -2, or -3 were co-expressed with either BSS 
To verify the in vivo results with in vitro determinations, 
the six SMT-like genes were expressed in yeast and 
microsomal preparations used as the source of the enzymes 
in assays containing 3H-SAM and either botryococcene or 
squalene as substrates. TMT-1 and TMT-2 readily catalyzed 
the transfer of a methyl group from SAM to squalene, but 
showed less than 1/Joo of those levels of activity with 
botryococcene as the acceptor (See Table 1) 
or SSL-1-3m, no distinct products could be detected in 
organic extracts by GC-MS analysis (data not shown); 
however, co-expression of TMT-1, -2, or -3 all resulted in 
the accumulation of several unique products (FIG. 5, rows 
TABLE 1 
Substrate preference of the various B. braunii SMT-like enzymesa 
Enzyme activity (pmoles/hlug) 
substrate empty TMT-1 TMT-2 TMT-3 SMT-1 SMT-2 SMT-3 
squalene 0 513.7 ± 8.6 862.2 ± 59.9 35.4 ± 3.0 0 0 0 
botryococcene 0 3.3 ± 1.3 4.5 ± 1.3 434.9 ± 31.8 0 0 0 
c32 squalene 0 0 0 0 0 0 0 
c32 botryococcene 0 0 0 0 0 0 0 
aTbe various B. braunii SMT-like genes or empty vector control were constitutively expressed in yeast for 3 days, after 
which microsomes were prepared according to the methods of Pompon et al. (36). Enzyme assays contained 50 mM 
HEPES, pH 7.5, either 0.01% (TMT-3) or 0.1% (all other samples) DHPC, 2 mM acceptor substrate (botryococcene, 
squalene, C32 botryococcene, C32 squalene), 50~ 3H-SAM (-150 dpm/pmole), 2 ~ aliquots of microsomes (-~g 
protein) in 100 ~final reaction volume. Assays were set up by first combining everything except 3H-SAM and 
microsomes, and sonicating the mixture until the solution became cloudy due to micelle formation. The 3H-SAM and 
microsomes were added, and the reaction incubated at 37° C. for 5 min. Reactions were stopped by adding an equal 
volume of 10% KOH in methanol, followed by extraction of hydrocarbon products with 400 ~ n-hexane. Aliquots of 
the hexane extract were separated by TLC and radioactivity incorporated into the triterpene fractions determined by 
scintillation counting. Data is reported as pmoles of methyl groups transferred to acceptor substrate per unit time and 
per ~g of microsomal protein. Data represents mean ± S.E.M., (of 3 replicates, i.e. n = 3) 
D-I). Analysis of the mass spectra of the unique peaks 
60 
showed parent ions of 424 and 438 amu (FIG. 10), suggest-
ing mono- and di-methylated triterpenes, respectively. 
When TMT-1 was co-expressed with BSS, 63% of the 
total squalenes accumulated as methyl-derivatives with 43% 
accumulating as dimethyl-squalene (FIG. 5, row D, FIG. 6, 65 
panel (A)). However, when coexpressed with SSL-1-3m, 
only 3% of the total botryococcenes accumulated as 
In contrast, TMT-3 favored botryococcene as the methyl 
acceptor and exhibited only very modest activity with 
squalene. None of the other 3 SMT-like genes showed any 
measurable methyltransferase activity with botryococcene 
or squalene as substrates. None of the six enzymes was able 
to methylate C32 botryococcene or C32 squalene, possible 
intermediates to the tetramethylated forms (see below). 
Equally surprising, none of the six B. braunii SMT-like 
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genes methylated cycloartenol, zymosterol, or lanosterol 
(data not shown), which suggested a proper substrate(s) for 
these MTs, that was not located this hydrophobic substrates 
were not in a form available for catalytic turnover, or that the 
MTs were not catalytically competent under these in vitro 
conditions. 
Chemical Identification of the Reaction Products-
To determine the specific methylation sites on squalene 
and botryococcene, the mono- and di-methylated squalenes 
and botryococcenes produced in vivo by the engineered 10 
yeast were purified and subjected to 1 H and 13C NMR 
analyses (see Tables 2-10, below for complete 13C NMR 
assignments). 
TABLE 2 15 
C31a botryococcene by TMT3 
C position 13C(o) 
17.78 20 
2 131.37 
124.47 
4 26.82 
39.81 
134.76 
7 124.91 25 
23.20 
9 41.41 
10 42.12 
11 135.91 
12 133.82 
13 36.84 30 
14 37.51 
15 25.92 
16 124.58 
17 135.11 
18 37.62 
19 33.44 
20 40.82 35 
21 150.27 
22 109.44 
23 25.79 
24 16.00 
25 23.63 
26 146.85 40 
27 111.20 
28 21.23 
29 16.07 
30 19.06 
31 19.76 
45 
TABLE 3 
C31 b botryococcene 
b TMT3 50 
C position 13C(o) 
2 
4 
7 
9 
10 
11 
12 
13 
14 
15 
16 
17 
109.44 
150.24 
40.82 
33.44 
37.58 
134.80 
124.80 
23.20 
41.45 
42.12 
135.89 
133.84 
36.77 
37.46 
25.90 
124.69 
135.07 
55 
60 
65 
18 
TABLE 3-continued 
C31 b botryococcene 
b TMT3 
C position 13C(o) 
18 39.81 
19 26.82 
20 124.50 
21 131.34 
22 17.78 
23 19.06 
24 16.00 
25 23.63 
26 146.85 
27 111.20 
28 21.23 
29 16.07 
30 25.79 
31 19.76 
TABLE 4 
C32 botryococcene 
b TMT3 
C position 13C(o) 
109.44 
2 150.23 
40.82 
4 33.44 
37.58 
135.07 
7 124.70 
23.19 
9 41.45 
10 42.11 
11 135.91 
12 133.82 
13 36.84 
14 37.51 
15 25.92 
16 124.58 
17 135.11 
18 37.62 
19 33.42 
20 40.84 
21 150.23 
22 109.44 
23 19.04 
24 16.00 
25 23.62 
26 146.84 
27 111.19 
28 21.23 
29 16.07 
30 19.04 
31 19.78 
32 19.78 
TABLE 5 
C31 sgualene by TMTl 
C position 13C(o) 
109.46 
2 150.25 
40.79 
4 33.42 
37.59 
134.99a 
7 124.49b 
26.85 
9 39.84 
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TABLE 5-continued TABLE 7-continued 
TMTl C31 squalene by TMT2 
C position 13C(o) C position 13C(o) 
10 135.19a 
11 124.40b 4 33.43 
12 28.36 37.59 
13 28.36 134.99a 
14 124.40b 7 124.49b 
15 135.17" 10 26.85 
16 39.81 c 
17 26.74d 9 39.84 
18 124.36 10 135.19a 
19 135.25a 11 124.40b 
20 39.81 c 12 28.36 
21 26.72d 15 13 28.36 
22 124.19 
23 131.34 
14 124.40b 
24 17.76 15 135.17" 
25 19.03 16 39.81 c 
26 16.09e 17 26.74d 
27 16.12e 20 18 124.36 
28 16.12" 19 135.25a 
29 16.09e 20 39.81 c 
30 25.79 21 26.72d 
31 19.76 22 124.19 
23 131.34 
25 24 17.76 
TABLE 6 25 19.03 
26 16.08e 
C32 sgualene by TMTl 27 16.13e 
28 16.13" 
C position 13C(o) 30 29 16.08e 
109.46 30 25.79 
2 150.23 31 19.76 
40.79 
4 33.43 
37.61 35 135.1sf TABLE 8 
7 124.19 
26.73 C32 sgualene by TMT2 
9 39.86 
10 135.2sf C position 13C(o) 
11 124.41 
12 28.37 40 109.45 
13 28.37 2 150.26 
14 124.41 40.79 
15 135.2sf 4 33.42 
16 39.86 37.59 
17 26.73 135.17f 
18 124.19 45 7 124.18 
19 135.1sf 26.71 
20 37.61 9 39.86 
21 33.43 10 135.2sf 
22 40.79 11 124.40 
23 150.23 12 28.35 
24 109.46 50 13 28.35 
25 19.03 14 124.40 
26 16.08g 15 135.2sf 
27 16.12g 16 39.86 
28 16.12g 17 26.71 
29 16.08g 18 124.18 
30 19.03 55 19 135.17f 31 19.78 20 37.59 
32 19.78 21 33.42 
22 40.79 
23 150.26 
24 109.45 
TABLE 7 25 19.04 60 26 16.08g 
C31 sgualene by TMT2 27 16.12g 
28 16.12g 
C position 13C(o) 29 16.08g 
30 19.04 
109.46 31 19.76 
2 150.26 65 32 19.76 
40.79 
21 
TABLE 9 
C31 squalene by TMT3 
C position 13C(o) 
109.45 
2 150.25 
40.79 
4 33.43 
37.60 
134.99a 
7 124.49b 
26.86 
9 39.84 
10 135.19a 
11 124.40b 
12 28.36 
13 28.36 
14 124.40b 
15 135.17" 
16 39.81 c 
17 26.75d 
18 124.36 
19 135.25a 
20 39.81 c 
21 26.72d 
22 124.19 
23 131.34 
24 17.75 
25 19.03 
26 16.09e 
27 16.12e 
28 16.12e 
29 16.09e 
30 25.79 
31 19.76 
TABLE 10 
C32 sgualene by TMT3 
C position 13C(o) 
109.46 
2 150.25 
40.79 
4 33.42 
37.60 
135.)(/ 
7 124.18 
26.73 
9 39.86 
10 135.2(/ 
11 124.40 
12 28.36 
13 28.36 
14 124.40 
15 135.2(/ 
16 39.86 
17 26.73 
18 124.18 
19 135.1(/ 
20 37.60 
21 33.42 
22 40.79 
23 150.25 
24 109.46 
25 19.04 
26 16.08g 
27 16.12g 
28 16.12g 
29 16.08g 
30 19.04 
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TABLE 1 0-continued 
C32 sgualene by TMT3 
C position 
31 
32 
19.78 
19.78 
a, b, c, d, e,J, gSignals with the same letter may be interchangeable in a same colunm. 
1H and 13C NMR spectra were recorded on a JEOL alpha 600 NMR spectrometer at 300K. 
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for botryococcenes and methylsqualenes to those previously reported 
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The mono-methylated squalenes produced by yeast 
expressing TMT-1, -2, or -3 were all identical based on their 
NMR signals and methylated at the C-3 position of squalene 
20 
(FIG. 7, compound 2). Similarly, all the di-methylated 
squalenes produced by all three yeast lines gave identical 
NMR signals indicative of methylation at the C-3 and C-22 
positions (FIG. 7, compound 3). In contrast, the mono-
methylated botryococcene produced by yeast expressing 
25 TMT-3 occurred at two positions, either the C-20 position 
yielding showacene (FIG. 7, compound 5) or the C-3 
position yielding isoshowacene (FIG. 7, compound 6). 
Based on the relative intensity of the NMR signals for the 
methyl substituent at C-20 in showacene (FIG. 7, compound 
30 5) versus that for C-3 in isoshowacene (FIG. 7, compound 
6), showacene accounts for more of the total mono-meth-
ylated products than isoshowacene. Di-methylated botryo-
coccene produced by TMT-3 had methyl groups at the C-3 
and C-20 positions (FIG. 7, compound 7). The very small 
35 amounts of methylated botryococcenes produced in yeast 
expressing TMT-1 or TMT-2 were not sufficient for NMR 
analysis; however, the GC-MS patterns of mono-methylated 
botryococcene produced by TMT-1, -2, and -3 were all 
identical (FIG. 10). These findings suggest that all the 
40 TMT's methylate botryococcene at identical positions. 
The large accumulation oftriterpene oils by Botryococcus 
braunii race B has provided the impetus for considerable 
interest in elucidating the biosynthesis of these seemingly 
simple molecules. The oil is composed largely of linear, 
45 branched-chain triterpenes resembling squalene, yet the 
triterpene scaffold, botryococcene, is synthesized by the 
successive action of two enzymes rather than a single 
enzyme like that typical for squalene biosynthesis (17). 
While small amounts of the C30 botryococcene and 
50 squalene triterpenes do accumulate, methylated forms of 
these molecules predominate and accumulate upwards of 
30% of the total algal dry weight. Hence, these algae must 
possess a robust mechanism(s) for converting the triterpene 
scaffolds to their methylated forms, that also lend these 
55 molecules to a variety industrial applications (23). 
In the current effort, three triterpene methyltransferases 
were identified which contribute to the methylation status of 
botryococcene and squalene, and biochemical properties 
were uncovered during this investigation. While three-trit-
60 erpene MTs genes were identified exhibiting sequence simi-
larity to sterol methyltransferases (FIG. 4), two of these 
encoded enzymes showed activity and specificity for 
squalene methylation. The third TMT appears to have speci-
ficity for botryococcene methylation. The specificity for 
65 squalene or botryococcene was unexpected because these 
molecules have very similar physical features. Nonetheless, 
the B. braunii TMTs were found to discriminate between the 
US 9,487,762 Bl 
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two methyl acceptors, as depicted in FIG. 8, and this must 
arise from the ability of the respective enzymes to recognize 
differences of the internal linkages within squalene and 
botryococcene. TMT-3 must be able to recognize the inter-
nal ethyl, methyl substituents at C-10 of botryococcene, 5 
while TMT-1 and -2 must prefer the straight-chain linkage 
across C-11, -12, -13 and -14 of squalene. 
The substrate specificity of the TMTs was unexpected 
when one considers the symmetry and asymmetry of 
squalene, botryococcene and the mono-methylated interme- 10 
diates, and the successive nature of these catalytic events. 
Most small molecule MTs catalyze mono-methylation reac-
tions, with some notable exceptions such as the tri-methyl-
ation of phosphoethanolamine in the biosynthesis of the 
choline head group in phospholipid biosynthesis (29). In 15 
contrast, the successive methylation of the sterol side-chain 
at C-24 requires distinct enzymes, sterol methyltransferases 
1 and 2 (30, 31). The successive nature of the B. braunii 
TMTs appears to represent yet another permutation in the 
activities of this diverse family of enzymes. For TMT-1 and 20 
-2, the symmetry of squalene affords equal probability of 
methylation at either end of the molecule, but these enzymes 
also introduce a second methylation at the equivalent posi-
tion on the other side of the molecule. While TMT-1 appears 
to perform this second methylation with great facility, this is 25 
not the case for TMT-2. The accumulation of di-methylated 
squalene exceeds that for mono-methylated squalene greater 
than 2-fold in yeast expressing the TMT-1 gene (FIG. 6, 
panel (A)), but di-methylated squalene only accumulates to 
approximately 20% of that for mono-methylated squalene in 30 
yeast expressing TMT-2 (FIG. 8, panel (B)). TMT-3 func-
tionally resembles TMT-1 with regards to the ease with 
which it introduces the second methylation into the botryo-
coccene backbone, that is, the accumulation of dimethyl-
botryococcene slightly exceeded that of monomethyl- 35 
botryococcene (FIG. 8, panel (F)). Based on NMR analysis 
of the mono-methylated botryococcene produced in yeast, 
showacene accumulated to higher levels than isoshowacene. 
It is unclear whether this arises from a preference for 
methylating botryococcene at C-20 rather than the C-3 40 
position with both monomethylated-botryococcenes serving 
as equal substrates in the second methylation reaction, or if 
both the C-3 and C-20 positions of botryococcene are 
methylated with equal efficiency but isoshowacene (meth-
ylated at C-3) is the preferred substrate for the second 45 
methylation reaction, or a combination of both possibilities. 
Regardless, a ratio of showacene to isoshowacene of 
approximately 1.7 to 1.0 is seen in mono-methylated botryo-
coccene isolated from B. braunii (31 ), suggesting that yeast 
expressing TMT-3 and SSL-1-3m recapitulate the same 50 
biochemical bias as observed in B. braunii. 
24 
ylation pattern of these triterpenes are also suitable in 
accordance with the present disclosure which are readily 
known or determined using routine experimentation known 
to one of ordinary skill in the art. 
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INCORPORATION BY REFERENCE 
All publication, patents, and patent applications men-
tioned in this specification are herein incorporated by ref-
erence to the same extent as if each individual publication, 
patent, or patent application was specifically and individu-
ally indicated to be incorporated by reference. 
It will be understood that various details of the presently 
disclosed subject matter can be changed without departing 
10 from the scope of the subject matter disclosed herein. 
Furthermore, the foregoing description is for the purpose of 
illustration only, and not for the purpose of limitation. 
>Seq1 [Botryococcus braunii race B] triterpene methyltransferase 1 (TMT-1) mRNA, 
complete cds 
(SEQ ID NO, 1) 
Atgggattggatctcctttcaacgtacgccccaggcatttttgacagtctcctgacttggaagggagtggctggtttggtcgttg 
ccattaccttgggctacctgatcatatctaggcttcctggacaaaagagccgtccaaagctattggatctaaagacaggag 
gtatctcctttgagaaggtcgcggccgtgtatgatgactacgacaagtcgtacggggagggagatcacggcgaactgcat 
gtcaaggacaagaacaaggtcttccaactggctaatactttctacgattttgtaactgatggttacgagtgggcatggggttc 
gagcttccacttctcccagcgcatgcccggcctgtcccatgcggcttcccagatgctccacgagtcgcgcatggcatctttttt 
gcgtctgaagccgggaatgaaatgcttggatgtgggctgtggtgtgggcaaccctggacggacagttgcgtcctgcagtg 
gggccgaggtcaccggcatcaccatcaatgagtaccagatcaagagggcagagtaccacaacaaaaggacgggctt 
ggtggggtacttcaaaccagtggtgggaaatttctgtgccatgccattcaaggataagacttttgatgctgctttcgccatgga 
ttccacttgccacgcacccaagctggaggacgtgtacagcgaagttttccgtgtcctgaagccaggaggcctgtttgccac 
atacgagtgggtctccaccaaagactacgaccccaacaactcccgacatgtgaaagtgatgaacagcatcatcttcggc 
aacggtcttccgaacattcggagctggaaacaggctgaggacgccgggaaaaacgtgggattcaagttggtgacaagc 
ttcgatctcgccaccgcccccccagttggcaagccctggtactatgtgcccgagctgatggtgaagtatgggctgctgacg 
attcagaaggctctagtgcgcggagcctgcaacgtgggcctccttcccaatgagggctggaaggtttgcaacatggtcgc 
cgacatggttcccaaccttgtcgagggtggcgcgacaaacatcttcacccccatgcacttgctcatctttgagaagcccaa 
gtga 
>Seq2 [Botryococcus braunii race B] triterpene methyltransferase 1 (TMT-2) mRNA, 
complete cds 
(SEQ ID NO, 2) 
Atggcagtagatttgctttcgatctatgggccaggcctttttgagagtcttctcacggtaaaaggcgctactggcttgatagctg 
ctcttatcttaggatacatcataataacaagactgcctggtcaaaagactaaacccaaattactggatttaacagcgggtgg 
tattccatttgagaaagtcggggaggtgtttaatgattacgacaaatcttatggaaagggaacccacggcgaattgcatgtc 
caggatacaaataaagtattccaattggcaaacacattttacgactttgtcactgatggttacgagtgggcctggggttcgag 
cttccacttctcacagcgcatgcctggcttgtctcatgcagcctcgcagatgctccatgaatcacggatggcatcttatctccgt 
ttgaagccagggatgacatgcttagacgtgggctgtggtgtgggcaacccgggaagaactgtagccgcatgcagtggtg 
cagttgtgactggaatcactataaacaagtaccagatccaaagggctgagtaccacaacagaaggacgggcttggtgg 
gattttttaaaccaacagttggaaacttctgcaacatgccatttgatgctaagtcttttgatgccgcttttgcaatggatgccactt 
gccacgcccccaagctggaagacgtgtatggggaggtcttccgcgtattgaagcctggaggcttctttgctacctatgagtg 
ggtttctacaaagaactatgaccccaccaacacgagacatgtcaaagtgatgaacagtatcatctttgggaacggtcttcc 
gaacataaggagctggaaacaagctgaggaggcaggggagaatgtgggatttaaactgttgacaagttttgaccttgca 
acagcgcccccagtgggaaagccctggtattatgtgccagagctgatggttaagtatgggcttctaaagatccagaaggc 
tctggtgcgcggagcctgcagcttgggtcttctccccgaccagagctggaaggtttgcaacatggtcgctgacatggttccc 
aaccttgtcgagggtggagcaacagacattttcacccctatgcacttgctgatcttccagaagccagaatga 
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-continued 
>Seq3 [Botryococcus braunii race B] triterpene methyltransferase 1 (TMT-3) mRNA, 
complete cds 
28 
(SEQ ID NO, 3) 
atggccctggatcttctttcatcctacgctcctggcttggtcgaaagcctgctaacatggaaaggcgcagccggcttggctgc 
agctgttgccctgggctatattattataagcaaccttcctggaaggcaggttgctaagcccagccttcttcaagtcagaactg 
gtggcgtcgccttcgagaaggtcgctgaggtagttgccgactacagtgactcttacgggcaaactgaaaagggcgactc 
atcgtcaaggacaacaacaagattgtctctctcgcgaatactttctatgacctcatcaccgatggatatgagtggggatggg 
gctccggcttccacttctctcataggctgccagggatgtccttcaatgcatctcagctgctccatgagtcccgtatggcgtctttc 
ctgcgcctgaagcccggcatgcaagttcttgatgttggctgcggtgtcggaaaccctggcagaacggttgctgcctgcagt 
ggagcagtggtgactggcatcaccatcaatgcataccagatcaagcgcgctgagttgcacactaagcgggcgggcttgg 
taggatacttcaagccagttcagggaaacttctgcgcgatgcctttccaagacaagagcttcgatgctgcctttgccatgga 
ctctacttgccatgcccccaagctggaggqtgtgtactccgaggtcttccgcgtgttgaagcctggcgcatactttgcaactta 
tgagtgggtgtctacaaagaactacgactccaacaacccagagcacgtgaagtgcatgaacagcatcatcctgggcaat 
ggcctgccgaacatcaggagttggaagcaagctgaggaggcagggaagaacgtgggtttcaacctgcttaccagcctc 
gacatggctacaaactcccccatcggaaagcctggtactctgtcccagagcgcatggtaaactggggcctgttccgtttc 
cacaaggcttgcattcgcactgcctctaccctgcatctgctgccgccagaatcctggaagttcttctacatccttgcagagat 
ggccgagaaccttgtaaagggtgggcaatgggacatcttcaccccatgcacttgctgatcttccaaaagccagagtaa 
>Seq4 [Botryococcus braunii race B] sterol methyltransferase-like 1 (SMT-1) mRNA, 
complete cds 
(SEQ ID NO, 4) 
atggcgtccgagctcttcgcgacatactaccctcgcgtggtagaggccgctcagcaactcgcaccatggcaaatcgctgc 
tggagtaaccgcggccgttgttattggtggctatatatggatcatcacagagcttcgtqgccctcgacgaacaggaactagt 
ctgttcaaattgtccggaggtggtattaagaagcacgatgtagcaaaattcatggacggctacgagaaatcatacaaaact 
caggaagacggtgcgctgacatggcaccacatcagcaaggaggactctgtcqagatggtgaacaccttctacgacctg 
gtcacagacgcgtatgagtgggcctgggacatctctttccacttctcctgccgacctgtgtgggccaactttgcccaggccc 
aagttctccatgagtgccgcattgccaacctggctcgcatccaacctggcatgaaagttattgatgttggcactggagtggg 
caaccccggccggaccattgcatcactgacgggggcccatgtgaccggtgtcaccatcaacgcataccagattaagcg 
ggcgctgcaccacacaaagaaggctggcctgttggacatgtacaaaccagtgcaggctgatttcaccgacatgcctttcg 
ccgacgagagttttgatgctgccttcgcaatgaagccacctgccacgcccccaagctggagcaagtatatgcagaagtg 
taccgcgtgctgaagccaggagcgtacttcgcagtgtatgaggccgtgtcaaagcccatttcgacccgaaaaacaaga 
ggcatgtcgagataatcaacagccttgtgtatggcaatggaatcccggacatgaggacctggaaggaagctgaggagg 
ccggaaagaaggtcggcttcaagcttcacttctcgtatgatgctggcgaggcttcctctgtcctggccccctggtgggagcg 
cccgagaaacttggtcaacaccggtgtcattgcatacactaaattcgccatcaaggtgtgtgacaagattggtatcctgcca 
agggactatgccaagttcgccaagtgtgtgggagattgcattcctgacgccgtggaatctggagagctgggcatcttcacc 
ccgatgtacgtgtacgtgtggcagaagccggagaagtcaacttaa 
>Seq5 [Botryococcus braunii race B] sterol methyltransferase-like 2 (SMT-2) mRNA, 
complete cds 
(SEQ ID NO, 5) 
Atggcggcagagctcatcaaggagtacgttcccattgtatcggagtatgcaccgggcctgatcgaaggtctcctatcatgg 
aaaggcgcagtcggcttggtcgcggccactggaattggctacgttcttatcattcaacggcttcaaaacacatctgcgacg 
aagaacttgtggggattgacaggaggtggtgtccaggctaaggatgtcagcaaggtcgcggacgtctacgataagtcgt 
acggcaaggagggggacggctccctcaccctgcaccatttggacaagaaggaatctgtggcggtcgtggacacgttcta 
caacctggtcacggatggctacgaggcgtgctggacaccagcttccatttctcgccgcgcccgcgattcaccaacttccg 
caccgctcagatcctgcacgaggctcgcatcggctacatggcccgcatccagccgggattcaaagttcttgactgcggct 
gtggaattgggaacccgggcaggactgtggcggctctcacaggggcccatgtgaccggcatcaccatcaatgagtacc 
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-continued 
aagtcaagagagctctgtaccacaccaagaaggcgggtttgacgggattgttcacgccagtgcaaggagacttcacag 
30 
acatgccttttgcggacaagactttcgatgctgctttcgccttgaggcgacctgccacgcacccaagctggagcaggtgta 
cggagagatcttccgcgtgctcaagccaggtgctttcttcgccgtgtacgaggccgtcaccaccgacaagttcgaccccgc 
caacaagcgccacgtcgagattatcaacagcctggtctacggcaacggcattccggacatgaggacatggaagcagg 
ctgaagaggcgggtaagaacgtgggcttcaagctgtgctgcgcatttgtgctggtgctgcttcacctgtggctctcccctgg 
tgggaacgcgtgaaggacatgatcaattggggcgttgtcaaatacacgaaggccgcctgcctggcgctggactccctcc 
gcttgctgcccaaggactactggaaagtagccaacatggtcggggacagccttcctgatctcgtcgagtctggggagacc 
gggatcttcacgccgatgtacctgctcgtgtggcaaaagcccgaggagtag 
>Seq6 [Botryococcus braunii race B] sterol methyltransferase-like 3 (SMT-3) mRNA, 
complete cds 
(SEQ ID NO, 6) 
Atggtgtcggagcttgtatcgatgtacgttcctcctattgtagaggctgccaaagccgtaacaccatggcaagcggctgctg 
gggtcactgcagccatttttataggatcatatctttggcacagtgcttcgcttcgcaaacaaagacgaacaggcactgcaga 
cggtggactgttttcgttgaccgcaggagggattaagaagcaagacgtaacaaaactcgtagactccttcagtcaagcat 
acaagacggaggacgacggccagcttacatgccaccatatcaccagggagcagtccgtggaaatggtaaacaccttct 
atgacctgatcacggacctttatgagtgggcctgggacacaagcttccacttctcgtgccgccccagatgggccaacttcg 
ctcaagcccaggtcctgcacgagtggcgcattgccaatcttgctaacattcagcccggcatgaaagtccttgatgttggaac 
cggagttggcaacccaggcaggacgattgcctctctctctggcgcccaagtgacaggagtcaccatcaatgcatatcaag 
tgaagcgcgctctgcaccacaccaggaaggctaaattggaagatttttacaaaccagtgcaggccgactttactgacacg 
cctttcgaagatgacactttcgatgctgcttttgcaattgaagccacctgccatgcccccaagctggagcaggtgtacaagg 
aagtgtaccgcgtgctgaagcctggagcgtacttcgctctttatgatggcgtgacaaagcccaactttgaccccaagaacg 
agaggcacgtgcaattgatgaacgctacggtgatcggcaacggatgcccggacatgaggacgtggaaggagtgtgag 
gagataggaaaggaggtcggcttcaagctgcacatgtcgtatgatgctggcgaagcttcccgcgtcctccacccctggtg 
ggagaaactcgacaacttcatcaacacaggctttgcgtggtatggaccggcctccattaagctcttgtcgaaaattggttttct 
gccaagggacttcacgaaattcatcgatattgcggcagctagtgttttctctgtcaaggaggctggagagcttggcattttca 
ctcccatgtacgtattcgtgtggcagaagccggagaagaccgcttga 
SEQUENCE LISTING 
<160> NUMBER OF SEQ ID NOS, 14 
<210> SEQ ID NO 1 
<211> LENGTH, 1137 
<212> TYPE, DNA 
<213> ORGANISM, Botryococcus braunii 
<400> SEQUENCE, 1 
atgggattgg atctcctttc aacgtacgcc ccaggcattt ttgacagtct cctgacttgg 60 
aagggagtgg ctggtttggt cgttgccatt accttgggct acctgatcat atctaggctt 120 
cctggacaaa agagccgtcc aaagctattg gatctaaaga caggaggtat ctcctttgag 180 
aaggtcgcgg ccgtgtatga tgactacgac aagtcgtacg gggagggaga tcacggcgaa 240 
ctgcatgtca aggacaagaa caaggtcttc caactggcta atactttcta cgattttgta 300 
actgatggtt acgagtgggc atggggttcg agcttccact tctcccagcg catgcccggc 360 
ctgtcccatg cggcttccca gatgctccac gagtcgcgca tggcatcttt tttgcgtctg 420 
aagccgggaa tgaaatgctt ggatgtgggc tgtggtgtgg gcaaccctgg acggacagtt 480 
gcgtcctgca gtggggccga ggtcaccggc atcaccatca atgagtacca gatcaagagg 540 
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-continued 
gcagagtacc acaacaaaag gacgggcttg gtggggtact tcaaaccagt ggtgggaaat 600 
ttctgtgcca tgccattcaa ggataagact tttgatgctg ctttcgccat ggattccact 660 
tgccacgcac ccaagctgga ggacgtgtac agcgaagttt tccgtgtcct gaagccagga 720 
ggcctgtttg ccacatacga gtgggtctcc accaaagact acgaccccaa caactcccga 780 
catgtgaaag tgatgaacag catcatcttc ggcaacggtc ttccgaacat tcggagctgg 840 
aaacaggctg aggacgccgg gaaaaacgtg ggattcaagt tggtgacaag cttcgatctc 900 
gccaccgccc ccccagttgg caagccctgg tactatgtgc ccgagctgat ggtgaagtat 960 
gggctgctga cgattcagaa ggctctagtg cgcggagcct gcaacgtggg cctccttccc 1020 
aatgagggct ggaaggtttg caacatggtc gccgacatgg ttcccaacct tgtcgagggt 1080 
ggcgcgacaa acatcttcac ccccatgcac ttgctcatct ttgagaagcc caagtga 1137 
<210> SEQ ID NO 2 
<211> LENGTH, 1137 
<212> TYPE, DNA 
<213> ORGANISM, Botryococcus braunii 
<400> SEQUENCE, 2 
atggcagtag atttgctttc gatctatggg ccaggccttt ttgagagtct tctcacggta 60 
aaaggcgcta ctggcttgat agctgctctt atcttaggat acatcataat aacaagactg 120 
cctggtcaaa agactaaacc caaattactg gatttaacag cgggtggtat tccatttgag 180 
aaagtcgggg aggtgtttaa tgattacgac aaatcttatg gaaagggaac ccacggcgaa 240 
ttgcatgtcc aggatacaaa taaagtattc caattggcaa acacatttta cgactttgtc 300 
actgatggtt acgagtgggc ctggggttcg agcttccact tctcacagcg catgcctggc 360 
ttgtctcatg cagcctcgca gatgctccat gaatcacgga tggcatctta tctccgtttg 420 
aagccaggga tgacatgctt agacgtgggc tgtggtgtgg gcaacccggg aagaactgta 480 
gccgcatgca gtggtgcagt tgtgactgga atcactataa acaagtacca gatccaaagg 540 
gctgagtacc acaacagaag gacgggcttg gtgggatttt ttaaaccaac agttggaaac 600 
ttctgcaaca tgccatttga tgctaagtct tttgatgccg cttttgcaat ggatgccact 660 
tgccacgccc ccaagctgga agacgtgtat ggggaggtct tccgcgtatt gaagcctgga 720 
ggcttctttg ctacctatga gtgggtttct acaaagaact atgaccccac caacacgaga 780 
catgtcaaag tgatgaacag tatcatcttt gggaacggtc ttccgaacat aaggagctgg 840 
aaacaagctg aggaggcagg ggagaatgtg ggatttaaac tgttgacaag ttttgacctt 900 
gcaacagcgc ccccagtggg aaagccctgg tattatgtgc cagagctgat ggttaagtat 960 
gggcttctaa agatccagaa ggctctggtg cgcggagcct gcagcttggg tcttctcccc 1020 
gaccagagct ggaaggtttg caacatggtc gctgacatgg ttcccaacct tgtcgagggt 1080 
ggagcaacag acattttcac ccctatgcac ttgctgatct tccagaagcc agaatga 1137 
<210> SEQ ID NO 3 
<211> LENGTH, 1140 
<212> TYPE, DNA 
<213> ORGANISM, Botryococcus braunii 
<400> SEQUENCE, 3 
atggccctgg atcttctttc atcctacgct cctggcttgg tcgaaagcct gctaacatgg 60 
aaaggcgcag ccggcttggc tgcagctgtt gccctgggct atattattat aagcaacctt 120 
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cctggaaggc aggttgctaa gcccagcctt cttcaagtca gaactggtgg cgtcgccttc 
gagaaggtcg ctgaggtagt tgccgactac agtgactctt acgggcaaac tgaaaagggc 
gaactcatcg tcaaggacaa caacaagatt gtctctctcg cgaatacttt ctatgacctc 
atcaccgatg gatatgagtg gggatggggc tccggcttcc acttctctca taggctgcca 
gggatgtcct tcaatgcatc tcagctgctc catgagtccc gtatggcgtc tttcctgcgc 
ctgaagcccg gcatgcaagt tcttgatgtt ggctgcggtg tcggaaaccc tggcagaacg 
gttgctgcct gcagtggagc agtggtgact ggcatcacca tcaatgcata ccagatcaag 
cgcgctgagt tgcacactaa gcgggcgggc ttggtaggat acttcaagcc agttcaggga 
aacttctgcg cgatgccttt ccaagacaag agcttcgatg ctgcctttgc catggactct 
acttgccatg cccccaagct ggaggatgtg tactccgagg tcttccgcgt gttgaagcct 
ggcgcatact ttgcaactta tgagtgggtg tctacaaaga actacgactc caacaaccca 
gagcacgtga agtgcatgaa cagcatcatc ctgggcaatg gcctgccgaa catcaggagt 
tggaagcaag ctgaggaggc agggaagaac gtgggtttca acctgcttac cagcctcgac 
atggctacaa actcccccat cggaaagccc tggtactctg tcccagagcg catggtaaac 
tggggcctgt tccgtttcca caaggcttgc attcgcactg cctctaccct gcatctgctg 
ccgccagaat cctggaagtt cttctacatc cttgcagaga tggccgagaa ccttgtaaag 
ggtgggcaat gggacatctt cacccccatg cacttgctga tcttccaaaa gccagagtaa 
<210> SEQ ID NO 4 
<211> LENGTH, 1170 
<212> TYPE, DNA 
<213> ORGANISM: Botryococcus braunii 
<400> SEQUENCE, 4 
atggcgtccg agctcttcgc gacatactac cctcgcgtgg tagaggccgc tcagcaactc 
gcaccatggc aaatcgctgc tggagtaacc gcggccgttg ttattggtgg ctatatatgg 
atcatcacag agcttcgtag ccctcgacga acaggaacta gtctgttcaa attgtccgga 
ggtggtatta agaagcacga tgtagcaaaa ttcatggacg gctacgagaa atcatacaaa 
actcaggaag acggtgcgct gacatggcac cacatcagca aggaggactc tgtcaagatg 
gtgaacacct tctacgacct ggtcacagac gcgtatgagt gggcctggga catctctttc 
cacttctcct gccgacctgt gtgggccaac tttgcccagg cccaagttct ccatgagtgc 
cgcattgcca acctggctcg catccaacct ggcatgaaag ttattgatgt tggcactgga 
gtgggcaacc ccggccggac cattgcatca ctgacggggg cccatgtgac cggtgtcacc 
atcaacgcat accagattaa gcgggcgctg caccacacaa agaaggctgg cctgttggac 
atgtacaaac cagtgcaggc tgatttcacc gacatgcctt tcgccgacga gagttttgat 
gctgccttcg caattgaagc cacctgccac gcccccaagc tggagcaagt atatgcagaa 
gtgtaccgcg tgctgaagcc aggagcgtac ttcgcagtgt atgaggccgt gtcaaagccc 
aatttcgacc cgaaaaacaa gaggcatgtc gagataatca acagccttgt gtatggcaat 
ggaatcccgg acatgaggac ctggaaggaa gctgaggagg ccggaaagaa ggtcggcttc 
aagcttcact tctcgtatga tgctggcgag gcttcctctg tcctggcccc ctggtgggag 
cgcccgagaa acttggtcaa caccggtgtc attgcataca ctaaattcgc catcaaggtg 
tgtgacaaga ttggtatcct gccaagggac tatgccaagt tcgccaagtg tgtgggagat 
tgcattcctg acgccgtgga atctggagag ctgggcatct tcaccccgat gtacgtgtac 
34 
180 
240 
300 
360 
420 
480 
540 
600 
660 
720 
780 
840 
900 
960 
1020 
1080 
1140 
60 
120 
180 
240 
300 
360 
420 
480 
540 
600 
660 
720 
780 
840 
900 
960 
1020 
1080 
1140 
US 9,487,762 Bl 
35 36 
-continued 
gtgtggcaga agccggagaa gtcaacttaa 1170 
<210> SEQ ID NO 5 
<211> LENGTH, 1170 
<212> TYPE, DNA 
<213> ORGANISM, Botryococcus braunii 
<400> SEQUENCE, 5 
atggcggcag agctcatcaa ggagtacgtt cccattgtat cggagtatgc accgggcctg 60 
atcgaaggtc tcctatcatg gaaaggcgca gtcggcttgg tcgcggccac tggaattggc 120 
tacgttctta tcattcaacg gcttcaaaac acatctgcga cgaagaactt gtggggattg 180 
acaggaggtg gtgtccaggc taaggatgtc agcaaggtcg cggacgtcta cgataagtcg 240 
tacggcaagg agggggacgg ctccctcacc ctgcaccatt tggacaagaa ggaatctgtg 300 
gcggtcgtgg acacgttcta caacctggtc acggatggct acgaggcgtg ctgggacacc 360 
agcttccatt tctcgccgcg cccgcgattc accaacttcc gcaccgctca gatcctgcac 420 
gaggctcgca tcggctacat ggcccgcatc cagccgggat tcaaagttct tgactgcggc 480 
tgtggaattg ggaacccggg caggactgtg gcggctctca caggggccca tgtgaccggc 540 
atcaccatca atgagtacca agtcaagaga gctctgtacc acaccaagaa ggcgggtttg 600 
acgggattgt tcacgccagt gcaaggagac ttcacagaca tgccttttgc ggacaagact 660 
ttcgatgctg ctttcgccat tgaggcgacc tgccacgcac ccaagctgga gcaggtgtac 720 
ggagagatct tccgcgtgct caagccaggt gctttcttcg ccgtgtacga ggccgtcacc 780 
accgacaagt tcgaccccgc caacaagcgc cacgtcgaga ttatcaacag cctggtctac 840 
ggcaacggca ttccggacat gaggacatgg aagcaggctg aagaggcggg taagaacgtg 900 
ggcttcaagc tgtgctgcgc atttgatgct ggtgctgctt cacctgtggc tctcccctgg 960 
tgggaacgcg tgaaggacat gatcaattgg ggcgttgtca aatacacgaa ggccgcctgc 1020 
ctggcgctgg actccctccg cttgctgccc aaggactact ggaaagtagc caacatggtc 1080 
ggggacagcc ttcctgatct cgtcgagtct ggggagaccg ggatcttcac gccgatgtac 1140 
ctgctcgtgt ggcaaaagcc cgaggagtag 1170 
<210> SEQ ID NO 6 
<211> LENGTH, 1179 
<212> TYPE, DNA 
<213> ORGANISM, Botryococcus braunii 
<400> SEQUENCE, 
atggtgtcgg agcttgtatc gatgtacgtt cctcctattg tagaggctgc caaagccgta 60 
acaccatggc aagcggctgc tggggtcact gcagccattt ttataggatc atatctttgg 120 
cacagtgctt cgcttcgcaa acaaagacga acaggcactg cagacggtgg actgttttcg 180 
ttgaccgcag gagggattaa gaagcaagac gtaacaaaac tcgtagactc cttcagtcaa 240 
gcatacaaga cggaggacga cggccagctt acatgccacc atatcaccag ggagcagtcc 300 
gtggaaatgg taaacacctt ctatgacctg atcacggacc tttatgagtg ggcctgggac 360 
acaagcttcc acttctcgtg ccgccccaga tgggccaact tcgctcaagc ccaggtcctg 420 
cacgagtggc gcattgccaa tcttgctaac attcagcccg gcatgaaagt ccttgatgtt 480 
ggaaccggag ttggcaaccc aggcaggacg attgcctctc tctctggcgc ccaagtgaca 540 
ggagtcacca tcaatgcata tcaagtgaag cgcgctctgc accacaccag gaaggctaaa 600 
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ttggaagatt tttacaaacc agtgcaggcc gactttactg acacgccttt cgaagatgac 
actttcgatg ctgcttttgc aattgaagcc acctgccatg cccccaagct ggagcaggtg 
tacaaggaag tgtaccgcgt gctgaagcct ggagcgtact tcgctcttta tgatggcgtg 
acaaagccca actttgaccc caagaacgag aggcacgtgc aattgatgaa cgctacggtg 
atcggcaacg gatgcccgga catgaggacg tggaaggagt gtgaggagat aggaaaggag 
gtcggcttca agctgcacat gtcgtatgat gctggcgaag cttcccgcgt cctccacccc 
tggtgggaga aactcgacaa cttcatcaac acaggctttg cgtggtatgg accggcctcc 
attaagctct tgtcgaaaat tggttttctg ccaagggact tcacgaaatt catcgatatt 
gcggcagcta gtgttttctc tgtcaaggag gctggagagc ttggcatttt cactcccatg 
tacgtattcg tgtggcagaa gccggagaag accgcttga 
<210> SEQ ID NO 7 
<211> LENGTH, 378 
<212> TYPE, PRT 
<213> ORGANISM: Botryococcus braunii 
<400> SEQUENCE, 7 
Met Gly Leu Asp Leu Leu Ser Thr Tyr Ala Pro Gly Ile Phe Asp Ser 
1 5 10 15 
Leu Leu Thr Trp Lys Gly Val Ala Gly Leu Val Val Ala Ile Thr Leu 
20 25 30 
Gly Tyr Leu Ile Ile Ser Arg Leu Pro Gly Gln Lys Ser Arg Pro Lys 
35 40 45 
Leu Leu Asp Leu Lys Thr Gly Gly Ile Ser Phe Glu Lys Val Ala Ala 
50 55 60 
Val Tyr Asp Asp Tyr Asp Lys Ser Tyr Gly Glu Gly Asp His Gly Glu 
65 70 75 80 
Leu His Val Lys Asp Lys Asn Lys Val Phe Gln Leu Ala Asn Thr Phe 
85 90 95 
Tyr Asp Phe Val Thr Asp Gly Tyr Glu Trp Ala Trp Gly Ser Ser Phe 
100 105 110 
His Phe Ser Gln Arg Met Pro Gly Leu Ser His Ala Ala Ser Gln Met 
115 120 125 
Leu His Glu Ser Arg Met Ala Ser Phe Leu Arg Leu Lys Pro Gly Met 
130 135 140 
Lys Cys Leu Asp Val Gly Cys Gly Val Gly Asn Pro Gly Arg Thr Val 
145 150 155 160 
Ala Ser Cys Ser Gly Ala Glu Val Thr Gly Ile Thr Ile Asn Glu Tyr 
165 170 175 
Gln Ile Lys Arg Ala Glu Tyr His Asn Lys Arg Thr Gly Leu Val Gly 
180 185 190 
Tyr Phe Lys Pro Val Val Gly Asn Phe Cys Ala Met Pro Phe Lys Asp 
195 200 205 
Lys Thr Phe Asp Ala Ala Phe Ala Met Asp Ser Thr Cys His Ala Pro 
210 215 220 
Lys Leu Glu Asp Val Tyr Ser Glu Val Phe Arg Val Leu Lys Pro Gly 
225 230 235 240 
Gly Leu Phe Ala Thr Tyr Glu Trp Val Ser Thr Lys Asp Tyr Asp Pro 
245 250 255 
Asn Asn Ser Arg His Val Lys Val Met Asn Ser Ile Ile Phe Gly Asn 
260 265 270 
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Gly Leu Pro Asn Ile Arg Ser Trp Lys Gln Ala Glu Asp Ala Gly Lys 
275 280 285 
Asn Val Gly Phe Lys Leu Val Thr Ser Phe Asp Leu Ala Thr Ala Pro 
290 295 300 
Pro Val Gly Lys Pro Trp Tyr Tyr Val Pro Glu Leu Met Val Lys Tyr 
305 310 315 320 
Gly Leu Leu Thr Ile Gln Lys Ala Leu Val Arg Gly Ala Cys Asn Val 
325 330 335 
Gly Leu Leu Pro Asn Glu Gly Trp Lys Val Cys Asn Met Val Ala Asp 
340 345 350 
Met Val Pro Asn Leu Val Glu Gly Gly Ala Thr Asn Ile Phe Thr Pro 
355 360 365 
Met His Leu Leu Ile Phe Glu Lys Pro Lys 
370 375 
<210> SEQ ID NO 8 
<211> LENGTH, 378 
<212> TYPE, PRT 
<213> ORGANISM: Botryococcus braunii 
<400> SEQUENCE, 8 
Met Ala Val Asp Leu Leu Ser Ile Tyr Gly Pro Gly Leu Phe Glu Ser 
1 5 10 15 
Leu Leu Thr Val Lys Gly Ala Thr Gly Leu Ile Ala Ala Leu Ile Leu 
20 25 30 
Gly Tyr Ile Ile Ile Thr Arg Leu Pro Gly Gln Lys Thr Lys Pro Lys 
35 40 45 
Leu Leu Asp Leu Thr Ala Gly Gly Ile Pro Phe Glu Lys Val Gly Glu 
50 55 60 
Val Phe Asn Asp Tyr Asp Lys Ser Tyr Gly Lys Gly Thr His Gly Glu 
65 70 75 80 
Leu His Val Gln Asp Thr Asn Lys Val Phe Gln Leu Ala Asn Thr Phe 
85 90 95 
Tyr Asp Phe Val Thr Asp Gly Tyr Glu Trp Ala Trp Gly Ser Ser Phe 
100 105 110 
His Phe Ser Gln Arg Met Pro Gly Leu Ser His Ala Ala Ser Gln Met 
115 120 125 
Leu His Glu Ser Arg Met Ala Ser Tyr Leu Arg Leu Lys Pro Gly Met 
130 135 140 
Thr Cys Leu Asp Val Gly Cys Gly Val Gly Asn Pro Gly Arg Thr Val 
145 150 155 160 
Ala Ala Cys Ser Gly Ala Val Val Thr Gly Ile Thr Ile Asn Lys Tyr 
165 170 175 
Gln Ile Gln Arg Ala Glu Tyr His Asn Arg Arg Thr Gly Leu Val Gly 
180 185 190 
Phe Phe Lys Pro Thr Val Gly Asn Phe Cys Asn Met Pro Phe Asp Ala 
195 200 205 
Lys Ser Phe Asp Ala Ala Phe Ala Met Asp Ala Thr Cys His Ala Pro 
210 215 220 
Lys Leu Glu Asp Val Tyr Gly Glu Val Phe Arg Val Leu Lys Pro Gly 
225 230 235 240 
Gly Phe Phe Ala Thr Tyr Glu Trp Val Ser Thr Lys Asn Tyr Asp Pro 
245 250 255 
Thr Asn Thr Arg His Val Lys Val Met Asn Ser Ile Ile Phe Gly Asn 
260 265 270 
40 
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Gly Leu Pro Asn Ile Arg Ser Trp Lys Gln Ala Glu Glu Ala Gly Glu 
275 280 285 
Asn Val Gly Phe Lys Leu Leu Thr Ser Phe Asp Leu Ala Thr Ala Pro 
290 295 300 
Pro Val Gly Lys Pro Trp Tyr Tyr Val Pro Glu Leu Met Val Lys Tyr 
305 310 315 320 
Gly Leu Leu Lys Ile Gln Lys Ala Leu Val Arg Gly Ala Cys Ser Leu 
325 330 335 
Gly Leu Leu Pro Asp Gln Ser Trp Lys Val Cys Asn Met Val Ala Asp 
340 345 350 
Met Val Pro Asn Leu Val Glu Gly Gly Ala Thr Asp Ile Phe Thr Pro 
355 360 365 
Met His Leu Leu Ile Phe Gln Lys Pro Glu 
370 375 
<210> SEQ ID NO 9 
<211> LENGTH, 379 
<212> TYPE, PRT 
<213> ORGANISM: Botryococcus braunii 
<400> SEQUENCE, 9 
Met Ala Leu Asp Leu Leu Ser Ser Tyr Ala Pro Gly Leu Val Glu Ser 
1 5 10 15 
Leu Leu Thr Trp Lys Gly Ala Ala Gly Leu Ala Ala Ala Val Ala Leu 
20 25 30 
Gly Tyr Ile Ile Ile Ser Asn Leu Pro Gly Arg Gln Val Ala Lys Pro 
35 40 45 
Ser Leu Leu Gln Val Arg Thr Gly Gly Val Ala Phe Glu Lys Val Ala 
50 55 60 
Glu Val Val Ala Asp Tyr Ser Asp Ser Tyr Gly Gln Thr Glu Lys Gly 
65 70 75 80 
Glu Leu Ile Val Lys Asp Asn Asn Lys Ile Val Ser Leu Ala Asn Thr 
85 90 95 
Phe Tyr Asp Leu Ile Thr Asp Gly Tyr Glu Trp Gly Trp Gly Ser Gly 
100 105 110 
Phe His Phe Ser His Arg Leu Pro Gly Met Ser Phe Asn Ala Ser Gln 
115 120 125 
Leu Leu His Glu Ser Arg Met Ala Ser Phe Leu Arg Leu Lys Pro Gly 
130 135 140 
Met Gln Val Leu Asp Val Gly Cys Gly Val Gly Asn Pro Gly Arg Thr 
145 150 155 160 
Val Ala Ala Cys Ser Gly Ala Val Val Thr Gly Ile Thr Ile Asn Ala 
165 170 175 
Tyr Gln Ile Lys Arg Ala Glu Leu His Thr Lys Arg Ala Gly Leu Val 
180 185 190 
Gly Tyr Phe Lys Pro Val Gln Gly Asn Phe Cys Ala Met Pro Phe Gln 
195 200 205 
Asp Lys Ser Phe Asp Ala Ala Phe Ala Met Asp Ser Thr Cys His Ala 
210 215 220 
Pro Lys Leu Glu Asp Val Tyr Ser Glu Val Phe Arg Val Leu Lys Pro 
225 230 235 240 
Gly Ala Tyr Phe Ala Thr Tyr Glu Trp Val Ser Thr Lys Asn Tyr Asp 
245 250 255 
Ser Asn Asn Pro Glu His Val Lys Cys Met Asn Ser Ile Ile Leu Gly 
42 
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260 265 270 
Asn Gly Leu Pro Asn Ile Arg Ser Trp Lys Gln Ala Glu Glu Ala Gly 
275 280 285 
Lys Asn Val Gly Phe Asn Leu Leu Thr Ser Leu Asp Met Ala Thr Asn 
290 295 300 
Ser Pro Ile Gly Lys Pro Trp Tyr Ser Val Pro Glu Arg Met Val Asn 
305 310 315 320 
Trp Gly Leu Phe Arg Phe His Lys Ala Cys Ile Arg Thr Ala Ser Thr 
325 330 335 
Leu His Leu Leu Pro Pro Glu Ser Trp Lys Phe Phe Tyr Ile Leu Ala 
340 345 350 
Glu Met Ala Glu Asn Leu Val Lys Gly Gly Gln Trp Asp Ile Phe Thr 
355 360 365 
Pro Met His Leu Leu Ile Phe Gln Lys Pro Glu 
370 375 
<210> SEQ ID NO 10 
<211> LENGTH, 389 
<212> TYPE, PRT 
<213> ORGANISM: Botryococcus braunii 
<400> SEQUENCE, 10 
Met Ala Ser Glu Leu Phe Ala Thr Tyr Tyr Pro Arg Val Val Glu Ala 
1 5 10 15 
Ala Gln Gln Leu Ala Pro Trp Gln Ile Ala Ala Gly Val Thr Ala Ala 
20 25 30 
Val Val Ile Gly Gly Tyr Ile Trp Ile Ile Thr Glu Leu Arg Ser Pro 
35 40 45 
Arg Arg Thr Gly Thr Ser Leu Phe Lys Leu Ser Gly Gly Gly Ile Lys 
50 55 60 
Lys His Asp Val Ala Lys Phe Met Asp Gly Tyr Glu Lys Ser Tyr Lys 
65 70 75 80 
Thr Gln Glu Asp Gly Ala Leu Thr Trp His His Ile Ser Lys Glu Asp 
85 90 95 
Ser Val Lys Met Val Asn Thr Phe Tyr Asp Leu Val Thr Asp Ala Tyr 
100 105 110 
Glu Trp Ala Trp Asp Ile Ser Phe His Phe Ser Cys Arg Pro Val Trp 
115 120 125 
Ala Asn Phe Ala Gln Ala Gln Val Leu His Glu Cys Arg Ile Ala Asn 
130 135 140 
Leu Ala Arg Ile Gln Pro Gly Met Lys Val Ile Asp Val Gly Thr Gly 
145 150 155 160 
Val Gly Asn Pro Gly Arg Thr Ile Ala Ser Leu Thr Gly Ala His Val 
165 170 175 
Thr Gly Val Thr Ile Asn Ala Tyr Gln Ile Lys Arg Ala Leu His His 
180 185 190 
Thr Lys Lys Ala Gly Leu Leu Asp Met Tyr Lys Pro Val Gln Ala Asp 
195 200 205 
Phe Thr Asp Met Pro Phe Ala Asp Glu Ser Phe Asp Ala Ala Phe Ala 
210 215 220 
Ile Glu Ala Thr Cys His Ala Pro Lys Leu Glu Gln Val Tyr Ala Glu 
225 230 235 240 
Val Tyr Arg Val Leu Lys Pro Gly Ala Tyr Phe Ala Val Tyr Glu Ala 
245 250 255 
44 
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Val Ser Lys Pro Asn Phe Asp Pro Lys Asn Lys Arg His Val Glu Ile 
260 265 270 
Ile Asn Ser Leu Val Tyr Gly Asn Gly Ile Pro Asp Met Arg Thr Trp 
275 280 285 
Lys Glu Ala Glu Glu Ala Gly Lys Lys Val Gly Phe Lys Leu His Phe 
290 295 300 
Ser Tyr Asp Ala Gly Glu Ala Ser Ser Val Leu Ala Pro Trp Trp Glu 
305 310 315 320 
Arg Pro Arg Asn Leu Val Asn Thr Gly Val Ile Ala Tyr Thr Lys Phe 
325 330 335 
Ala Ile Lys Val Cys Asp Lys 
340 
Lys Phe Ala Lys Cys Val Gly 
355 
Gly Glu Leu Gly Ile Phe 
370 
Pro Glu Lys Ser Thr 
385 
<210> SEQ ID NO 11 
<211> LENGTH, 389 
<212> TYPE, PRT 
Thr 
375 
Ile Gly Ile Leu Pro Arg 
345 
Asp Cys Ile Pro Asp Ala 
360 365 
Pro Met Tyr Val Tyr Val 
380 
<213> ORGANISM: Botryococcus braunii 
<400> SEQUENCE, 11 
Asp Tyr Ala 
350 
Val Glu Ser 
Trp Gln Lys 
Met Ala Ala Glu Leu Ile Lys Glu Tyr Val Pro Ile Val Ser Glu Tyr 
1 5 10 15 
Ala Pro Gly Leu Ile Glu Gly Leu Leu Ser Trp Lys Gly Ala Val Gly 
20 25 30 
Leu Val Ala Ala Thr Gly Ile Gly Tyr Val Leu Ile Ile Gln Arg Leu 
35 40 45 
Gln Asn Thr Ser Ala Thr Lys Asn Leu Trp Gly Leu Thr Gly Gly Gly 
50 55 60 
Val Gln Ala Lys Asp Val Ser Lys Val Ala Asp Val Tyr Asp Lys Ser 
65 70 75 80 
Tyr Gly Lys Glu Gly Asp Gly Ser Leu Thr Leu His His Leu Asp Lys 
85 90 95 
Lys Glu Ser Val Ala Val Val Asp Thr Phe Tyr Asn Leu Val Thr Asp 
100 105 110 
Gly Tyr Glu Ala Cys Trp Asp Thr Ser Phe His Phe Ser Pro Arg Pro 
115 120 125 
Arg Phe Thr Asn Phe Arg Thr Ala Gln Ile Leu His Glu Ala Arg Ile 
130 135 140 
Gly Tyr Met Ala Arg Ile Gln Pro Gly Phe Lys Val Leu Asp Cys Gly 
145 150 155 160 
Cys Gly Ile Gly Asn Pro Gly Arg Thr Val Ala Ala Leu Thr Gly Ala 
165 170 175 
His Val Thr Gly Ile Thr Ile Asn Glu Tyr Gln Val Lys Arg Ala Leu 
180 185 190 
Tyr His Thr Lys Lys Ala Gly Leu Thr Gly Leu Phe Thr Pro Val Gln 
195 200 205 
Gly Asp Phe Thr Asp Met Pro Phe Ala Asp Lys Thr Phe Asp Ala Ala 
210 215 220 
Phe Ala Ile Glu Ala Thr Cys His Ala Pro Lys Leu Glu Gln Val Tyr 
225 230 235 240 
46 
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Gly Glu Ile Phe Arg Val Leu Lys Pro Gly Ala Phe Phe Ala Val Tyr 
245 250 255 
Glu Ala Val Thr Thr Asp Lys Phe Asp Pro Ala Asn Lys Arg His Val 
260 265 270 
Glu Ile Ile Asn Ser Leu Val Tyr Gly Asn Gly Ile Pro Asp Met Arg 
275 280 285 
Thr Trp Lys Gln Ala Glu Glu Ala Gly Lys Asn Val Gly Phe Lys Leu 
290 295 300 
Cys Cys Ala Phe Asp Ala Gly Ala Ala Ser Pro Val Ala Leu Pro Trp 
305 310 315 320 
Trp Glu Arg Val Lys Asp Met Ile Asn Trp Gly Val Val Lys Tyr Thr 
325 330 335 
Lys Ala Ala Cys Leu Ala Leu Asp 
340 
Tyr Trp Lys Val Ala Asn Met 
355 
Glu Ser Gly Glu Thr Gly 
370 
Gln Lys Pro Glu Glu 
385 
<210> SEQ ID NO 12 
<211> LENGTH, 392 
<212> TYPE, PRT 
Ile 
375 
Val 
360 
Phe 
Ser Leu Arg Leu Leu 
345 
Gly Asp Ser Leu Pro 
365 
Thr Pro Met Tyr Leu 
380 
<213> ORGANISM: Botryococcus braunii 
<400> SEQUENCE, 12 
Pro Lys Asp 
350 
Asp Leu Val 
Leu Val Trp 
Met Val Ser Glu Leu Val Ser Met Tyr Val Pro Pro Ile Val Glu Ala 
1 5 10 15 
Ala Lys Ala Val Thr Pro Trp Gln Ala Ala Ala Gly Val Thr Ala Ala 
20 25 30 
Ile Phe Ile Gly Ser Tyr Leu Trp His Ser Ala Ser Leu Arg Lys Gln 
35 40 45 
Arg Arg Thr Gly Thr Ala Asp Gly Gly Leu Phe Ser Leu Thr Ala Gly 
50 55 60 
Gly Ile Lys Lys Gln Asp Val Thr Lys Leu Val Asp Ser Phe Ser Gln 
65 70 75 80 
Ala Tyr Lys Thr Glu Asp Asp Gly Gln Leu Thr Cys His His Ile Thr 
85 90 95 
Arg Glu Gln Ser Val Glu Met Val Asn Thr Phe Tyr Asp Leu Ile Thr 
100 105 110 
Asp Leu Tyr Glu Trp Ala Trp Asp Thr Ser Phe His Phe Ser Cys Arg 
115 120 125 
Pro Arg Trp Ala Asn Phe Ala Gln Ala Gln Val Leu His Glu Trp Arg 
130 135 140 
Ile Ala Asn Leu Ala Asn Ile Gln Pro Gly Met Lys Val Leu Asp Val 
145 150 155 160 
Gly Thr Gly Val Gly Asn Pro Gly Arg Thr Ile Ala Ser Leu Ser Gly 
165 170 175 
Ala Gln Val Thr Gly Val Thr Ile Asn Ala Tyr Gln Val Lys Arg Ala 
180 185 190 
Leu His His Thr Arg Lys Ala Lys Leu Glu Asp Phe Tyr Lys Pro Val 
195 200 205 
Gln Ala Asp Phe Thr Asp Thr Pro Phe Glu Asp Asp Thr Phe Asp Ala 
48 
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210 215 220 
Ala Phe Ala Ile Glu Ala Thr Cys His Ala Pro Lys Leu Glu Gln Val 
225 230 235 240 
Tyr Lys Glu Val Tyr Arg Val Leu Lys Pro Gly Ala Tyr Phe Ala Leu 
245 250 255 
Tyr Asp Gly Val Thr Lys Pro Asn Phe Asp Pro Lys Asn Glu Arg His 
260 265 270 
Val Gln Leu Met Asn Ala Thr Val Ile Gly Asn Gly Cys Pro Asp Met 
275 280 285 
Arg Thr Trp Lys Glu Cys Glu Glu Ile Gly Lys Glu Val Gly Phe Lys 
290 295 300 
Leu His Met Ser Tyr Asp Ala Gly Glu Ala Ser Arg Val Leu His Pro 
305 310 315 320 
Trp Trp Glu Lys Leu Asp Asn Phe Ile Asn Thr Gly Phe Ala Trp Tyr 
325 330 335 
Gly Pro Ala Ser Ile Lys Leu Leu Ser Lys Ile Gly Phe Leu Pro Arg 
340 345 350 
Asp Phe Thr Lys Phe Ile Asp Ile Ala Ala Ala Ser Val Phe Ser Val 
355 360 365 
Lys Glu Ala Gly Glu Leu Gly Ile Phe Thr Pro Met Tyr Val Phe Val 
370 375 380 
Trp Gln Lys Pro Glu Lys Thr Ala 
3 85 3 90 
<210> SEQ ID NO 13 
<211> LENGTH, 387 
<212> TYPE, PRT 
<213> ORGANISM, Chlamydomonas reinhardtii 
<400> SEQUENCE, 13 
Met Ala Val Ala Leu Pro Ala Ala Val Thr Ser Ala Tyr Glu Arg Leu 
1 5 10 15 
Ala Gly Glu Phe Asp Lys Leu Ser Thr Thr Gln Lys Tyr Ala Val Gly 
20 25 30 
Ile Ala Gly Gly Val Thr Ser Leu Tyr Leu Leu Ala Lys Val Leu Lys 
35 40 45 
Gly Ser Asp Arg Asp Lys Pro Thr Thr Leu Gln Leu Ser Gly Gly Ser 
50 55 60 
Ile Asp Ser Ser Lys Val Lys Asp Glu Phe Thr Ala Tyr Ala Asp Ser 
65 70 75 80 
Tyr Gly Lys Asn Ala Gly Glu Gly Ile Thr Asp Arg Ser Lys Thr Val 
85 90 95 
His Leu Val Asp Val Phe Tyr Ser Leu Val Thr Asp Ile Tyr Glu Trp 
100 105 110 
Gly Trp Gly Gln Ser Phe His Phe Ser Pro Lys Leu Pro Asn Lys Asp 
115 120 125 
Leu Lys Ala Ser Glu Ala Ala His Glu Ala Arg Ile Ala Ala Leu Leu 
130 135 140 
Arg Leu Gln Pro Gly Gln Lys Ala Leu Asp Cys Gly Cys Gly Val Gly 
145 150 155 160 
Gly Pro Met Arg Thr Val Ala Ala Val Ser Gly Ala His Ile Thr Gly 
165 170 175 
Ile Thr Ile Asn Gln Tyr Gln Val Asp Arg Ala Lys Thr His Asn Ala 
180 185 190 
50 
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Arg Gln Gly Leu Ala Pro Leu Thr Asp Val Val Arg Gly Asp Phe Thr 
195 200 205 
Asn Met Pro Phe Lys Glu Asn Thr Phe Asp Gly Ala Tyr Ala Ile Glu 
210 215 220 
Ala Thr Cys His Ala Pro Lys Leu Glu Gln Val Tyr Gly Glu Ile Tyr 
225 230 235 240 
Arg Val Leu Lys Pro Gly Ser Tyr Phe Val Ser Tyr Glu Trp Val Ser 
245 250 255 
Thr Gln Lys Phe Asp Val Asn Asn Ala Glu His Val Lys Ile Met Asp 
260 265 270 
Glu Ile Asn Phe Gly Asn Gly Leu Pro Glu Met Arg Thr Trp Lys Glu 
275 280 285 
Ala Glu Asp Ala Gly Lys Asn Val Gly Phe Glu Leu Val Met Ser Leu 
290 295 300 
Asp Leu Ala Thr Ala Ser Val Val Ala Gly Pro Trp Tyr Glu Arg Leu 
305 310 315 320 
Arg Met Gly Lys Tyr Thr His Ala Ile Asn His Gly Ile Val Ser Thr 
325 330 335 
Val Asp Ala Leu Gly Leu Ala Pro Lys Gly Leu Lys Glu Val His His 
340 345 350 
Met Leu Val Glu Val Ala Lys Ser Leu Ile Gln Gly Gly Glu Ser Gly 
355 360 365 
Ile Phe Thr Pro Met His Leu Leu Leu Phe Arg Lys Pro Gly Ala Asp 
370 375 380 
Lys Lys Lys 
385 
<210> SEQ ID NO 14 
<211> LENGTH, 336 
<212> TYPE, PRT 
<213> ORGANISM, Arabidopsis thaliana 
<400> SEQUENCE, 14 
Met Asp Leu Ala Ser Asn Leu Gly Gly Lys Ile Asp Lys Ser Asp Val 
1 5 10 15 
Leu Thr Ala Val Glu Lys Tyr Glu Gln Tyr His Val Phe His Gly Gly 
20 25 30 
Asn Glu Glu Glu Arg Lys Ala Asn Tyr Thr Asp Met Val Asn Lys Tyr 
35 40 45 
Tyr Asp Leu Ala Thr Ser Phe Tyr Glu Tyr Gly Trp Gly Glu Ser Phe 
50 55 60 
His Phe Ala Gln Arg Trp Lys Gly Glu Ser Leu Arg Glu Ser Ile Lys 
65 70 75 80 
Arg His Glu His Phe Leu Ala Leu Gln Leu Gly Ile Gln Pro Gly Gln 
85 90 95 
Lys Val Leu Asp Val Gly Cys Gly Ile Gly Gly Pro Leu Arg Glu Ile 
100 105 110 
Ala Arg Phe Ser Asn Ser Val Val Thr Gly Leu Asn Asn Asn Glu Tyr 
115 120 125 
Gln Ile Thr Arg Gly Lys Glu Leu Asn Arg Leu Ala Gly Val Asp Lys 
130 135 140 
Thr Cys Asn Phe Val Lys Ala Asp Phe Met Lys Met Pro Phe Pro Glu 
145 150 155 160 
Asn Ser Phe Asp Ala Val Tyr Ala Ile Glu Ala Thr Cys His Ala Pro 
165 170 175 
52 
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Asp Ala Tyr Gly Cys Tyr Lys Glu Ile Tyr Arg Val Leu Lys Pro Gly 
180 185 190 
Gln Cys Phe Ala Ala Tyr Glu Trp Cys Met Thr Asp Ala Phe Asp Pro 
195 200 205 
Asp Asn Ala Glu His Gln Lys Ile Lys Gly Glu Ile Glu Ile Gly Asp 
210 215 220 
Gly Leu Pro Asp Ile Arg Leu Thr Thr Lys Cys Leu Glu Ala Leu Lys 
225 230 235 240 
Gln Ala Gly Phe Glu Val Ile Trp Glu Lys Asp Leu Ala Lys Asp Ser 
245 250 255 
Pro Val Pro Trp Tyr Leu Pro Leu Asp Lys Asn His Phe Ser Leu Ser 
260 265 270 
Ser Phe Arg Leu Thr Ala Val Gly Arg Phe Ile Thr Lys Asn Met Val 
275 280 285 
Lys Ile Leu Glu Tyr Ile Arg Leu Ala Pro Gln Gly Ser Gln Arg Val 
290 295 300 
Ser Asn Phe Leu Glu Gln Ala Ala Glu Gly Leu Val Asp Gly Gly Arg 
305 310 315 320 
Arg Glu Ile Phe Thr Pro Met Tyr Phe Phe Leu Ala Arg Lys Pro Glu 
325 330 
The invention claimed is: 
1. An expression vector comprising (i) a promoter non-
native to TMT-1 and TMT-2 and a nucleic acid having (ii) 
335 
10. The transfected cell of claim 9, wherein the nucleic 
30 
acid comprises a chloroplast target sequence, wherein, when 
the nucleic acid is expressed in the plant cell, the protein is 
directed to its chloroplasts. a nucleic acid sequence encoding a protein selected from the 
group consisting oftriterpene methyltransferase 1 (TMT-1) 
and triterpene methyltransferase 2 (TMT-2), selected from 
the group consisting of SEQ ID NOS: 1 and 2, wherein 35 
TMT-1 and TMT-2 have specificity for squalene and not 
botryococcene. 
11. The transfected cell of claim 9, wherein the nucleic 
acid further comprises a sequence encoding at least one 
triterpene synthase. 
12. The transfected cell of claim 11, wherein the at least 
one triterpene synthase is a squalene synthase. 2. The expression vector of claim 1, wherein the nucleic 
acid sequence consists of both SEQ ID NOS: 1 and 2. 
3. The expression vector of claim 1, wherein the nucleic 40 
acid further comprises a sequence encoding at least one 
triterpene synthase. 
13. The expression vector of claim 12, wherein the nucleic 
acid further comprises a sequence encoding prenyltrans-
ferase. 
14. The transfected cell of claim 13, wherein the nucleic 
4. The expression vector of claim 3, wherein the at least 
one triterpene synthase is a squalene synthase. 
5. The expression vector of claim 3, wherein the at least 45 
one triterpene synthase is from Botryococcus braunii. 
acid comprises at least one chloroplast target sequence, 
wherein, when the nucleic acid is expressed in the plant cell, 
the triterpene methyltransferase, the at least one triterpene 
synthase and the prenyltransferase are directed to its chlo-
6. The expression vector of claim 1, wherein the nucleic 
acid further comprises a sequence encoding prenyltrans-
ferase. 
7. The expression vector of claim 1, wherein the nucleic 
acid comprises a chloroplast target sequence, wherein, when 
the nucleic acid is expressed in a plant cell with chloroplasts, 
the protein is directed to the chloroplasts. 
8. The expression vector of claim 3, wherein the nucleic 
acid comprises a chloroplast target sequence, wherein, when 
the nucleic acid is expressed in a plant cell with chloroplasts, 
the least one triterpene synthase is directed to the chloro-
plasts. 
9. A transfected cell comprising a plant cell with an 
expression vector comprising a nucleic acid having (i) a 
non-native TMT-1 or TMT-2 promoter and (ii) a nucleic acid 
sequence encoding a protein selected from the group con-
sisting of triterpene methyltransferase 1 (TMT-1) and trit-
erpene methyltransferase 2 (TMT-2), selected from the 
group consisting of SEQ ID NOS: 1 and 2, wherein TMT-1 
and TMT-2 have specificity for squalene and not botryococ-
cene. 
roplasts. 
15. A method for transforming a cell comprising trans-
fecting a plant cell with an expression vector comprising (i) 
50 a promoter not native to TMT-1 and TMT-2 and (ii) a nucleic 
acid having a nucleic acid sequence encoding at least one 
protein selected from the group consisting of triterpene 
methyltransferase 1 (TMT-1) and triterpene methyltrans-
ferase 2 (TMT-2), selected from the group consisting of SEQ 
55 ID NOS: 1 and 2 wherein TMT-1 and TMT-2 have speci-
ficity for squalene and not botryococcene. 
16. The method of claim 15, wherein the at least one 
protein comprises both TMT-1 and TMT-2. 
17. The method of claim 15, wherein the nucleic acid 
60 comprises a chloroplast target sequence, wherein, when the 
nucleic acid is expressed in the plant cell, the protein is 
directed to its chloroplasts. 
18. The method of claim 15, wherein the nucleic acid 
further comprises a sequence encoding at least one triterpene 
65 synthase. 
19. The method of claim 18, wherein the at least one 
triterpene synthase is a squalene synthase. 
US 9,487,762 Bl 
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20. The method of claim 19, wherein the nucleic acid 
further comprises a sequence encoding prenyltransferase. 
21. The method of claim 20, wherein the nucleic acid 
comprises at least one chloroplast target sequence, wherein, 
when the nucleic acid is expressed in the plant cell, the 
triterpene methyltransferase, the at least one triterpene syn-
thase and the prenyltransferase are directed to its chloro-
plasts. 
22. The expression vector of claim 1, wherein the nucleic 
acid is eDNA. 10 
23. The expression vector of claim 1, wherein the nucleic 
acid is eDNA. 
24. The transfected cell of claim 9, wherein the nucleic 
acid is eDNA. 
25. The method of claim 15, wherein the nucleic acid is 15 
from eDNA. 
* * * * * 
